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This "l’hes is is a remort of an i nv est iga t ion 
into the prepo.raticn of thi on a oh th en isosteres of 
b i o j o p i c a.1 I. y acfi.we indole conrooiinds.
The in tro due t i.on deals with the theoretical 
ir'pi ics tion s of the vs.rious approaches to the s^'^ntheses 
of biologicall.y active compounds, and. in particular 
those with an indole nucleus present in the molecule.
A review 0 1^. " i o 1 o c i c s 1 tctivi.ty in Compounds Possessing 
Ah io 3'^'*''en p i-K-, g c" is in c''.ud ed . a (4 i u s t i f ic a tion is 
urovided for the ur epa r? t ion of th i.ona.uh th en i so s ter e s 
of such comrounds as d-hydroxytryptamine .
Tn section 1, the nosition of electrophilic 
subs t i tut ion in 9- subs ti tu ted th :I.onaph th en s wa.s investigated, 
with a. view to emwl eying the various uro tec tin g grouns 
in a s2m.th es,i.s of thie thionauh th en analogue of 5-hydroxy- 
tr^^ptanine. Other interesting orientation effects s.re 
also reported.
Section 2 deals with the prepa,ration of Vcarious 
th ionaoh th en derivatives con to in in r a gram in e sid e-chain 
c s Tvossible antagonists of adrenaline and of ^-hydrox^f- 
tr ta.m in e .
In section J, attempts to prepare ?-(2'-amino 
ethyl )-5""hydroxythionaphth en , the t h ionanh th en 
analogue of 5 -hydro xy try p tarn in e , are reported.
Various other isosteres of ^-hyd roxytryp tarn in e-1ik e 
compound s including d-( 2 ’-a.rai no ethyl )-é-hydroxy- 
thionaphthen are reported. Section J also deals with 
the synth e s e s of thionaphthen analogues of harm in e 
and harma line.
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I Theoretical Considerations.
The major difficulty confronting attempts to 
design new compounds possessing specifically desired 
medicinal properties is the lack of a simple correlation 
between chemical structure and biological activity.
In part this may be due to the extensive gaps which 
exist in our knowledge of the exact manner in which 
drugs affect the delicately balanced processes that 
together constitute the normal functioning of tissues. 
Again, much of the data which is available may not be 
fully utilised because of our frequent inability to 
integrate information gained in the different biological 
disciplines or to weld together the concepts of other 
scientific endeavours into applicable theories. But 
even if these handicaps were to be overcome, there are 
two main reasons why comprehensive structure-action 
relationships are virtually impossible to establish.
In the first place, the same overall biological 
effect may be elicited by a variety of mechanisms, and 
it cannot reasonably be expected that drugs acting by 
different mechanisms should necessarily show any 
chemical or physical similarities. A detailed study of
the intimate mechanism by which a drug acts usually
necessitates work at the biochemical level, and the 
issue is then often complicated by the uncertainty 
of applying results obtained tn vitro to ^  vivo 
systems. Moreover, so many facts are often obtained 
from the iui vitro system that the basic mechanism 
involved is not clear because one cannot unambiguously 
establish the relationship between the primary cause 
and the resultant effects.
In the second place, numerous factors are 
simultaneously involved in conferring upon a drug its 
characteristic mode of action, of which chemical structure 
is but one, and this cannot be considered out of the 
context of the other variables. Also, the great 
sensitivity and delicacy of the animal organism seriously 
limits intentional variation of such factors as pH, 
temperature, and osmotic pressure. Thus, the large 
number of variable factors and the restricted range of 
intentional variation tolerated vivo hinder the
establishment in pharmacology of fundamental quantitative 
laws capable of mathematical expression such as those 
characteristic of the more exact sciences of chemistry 
and physics.
Some of the more important variables known to 
influence drug action are genetic constitution 
(comprising species, strain, individual, and sexual 
differences), tissue constitution, and the weight, age, 
and condition of health of the test subject. These 
factors can be collectively grouped as variables 
inherent in the biological system. By selecting for 
homogeneity in the biological system, be it whole 
animal or tissue, one can minimise these variables.
There is, however, a residual variation which in practice 
cannot be eliminated, necessitating analysis of the 
experimental data by statistical methods before valid 
conclusions can be drawn. This residual variation may 
be due to a variety of factors not the least important 
of which are differences in the rates of absorption, 
penetration, biotransformation, and elimination of the 
drug.
Another group of variables which affect drug 
action are those pertaining to the experimental 
conditions. These include such factors as the dose and 
physical state of the drug, the route, frequency, speed 
and timing of its administration, the dietary history 
of the experimental animal, the temperature, the
ysimultaneous presence of other drugs in the system 
and the pH. Such variables are usually subject to a 
considerable degree of control.
Finally, there is a third group of factors 
known to influence drug action - the physico-chemical 
variables. Althoughi these are uniquely defined for any 
given substance, they do not necessarily vary in like 
manner with change in chemical structure, so they must 
be considered separately when comparison is made between 
the biological actions of more than one drug. Such 
variables which include solubilities, distribution 
coefficients, electrical fields, inductive effects, 
pKgL*s, and steric effects, play an important role in 
determining the ease with which a drug can penetrate 
the various permeability barriers in the body (for 
example, the blood-brain barrier) before reaching its 
potential site of action.
Despite the non-existence of an overall theory 
relating drug action to chemical structure, there are, 
nevertheless, a number of theories of limited application 
which can be invoked to aid in the design of new 
biologically active compounds. Among these are the 
receptor theory of drug action, the theory of metabolite
displacement, and the concept of bioisosterism. Because 
these three concepts together represent theoretical 
justification for the present work, they will be briefly 
sumrnarised.
A . The Receptor Theory of Drug Action .
In general, biologically active compounds can
be conveniently considered as belonging to one of two
groups - the structurally specific and the structurally
non-specific,^ although as is the case with all
biological classifications, there are no hard and fast
lines of demarcation between the two groups, one
merging into the other by way of compounds possessing
intermediate properties. Truly structurally non-specific
drugs exhibit biological activity solely by virtue of
their favourable physical properties- in accordance with
2
the principle so elegantly established by Ferguson, 
and this activity is quite independent of their 
functional groups. Examples of such structurally non­
specific compounds are to be found in the general 
anaesthetics such as ether, chloroform, cyclopropane, 
ethylene dichloride, nitrous oxide, and the inert gases.
Structurally specific drugs on the other hand 
are thought to exert their effects by interacting with
specific receptors in the tissues which impose 
restrictions on the size, shape, and electrical 
properties of molecules capable of complexing with them. 
The receptor theory has been implicitly accepted by 
many workers in pharmacology and chemotherapy and 
related fields for a number of years. It was inherent
in the lock and key analogy of Fischer^ and the concept
4
was used by Clark and others to afford a theoretical 
basis for the interpretation of experimental dose-response 
curves. The binding forces of the drug receptor complex 
are in the majority of cases of such a nature as to be 
readily reversible at room temperature, and involve 
energy values of the same order as those of heterogeneous 
catalysis. The fact that virtually every class of drug 
can be removed quickly and completely from animal tissue 
by dialysis or simple solvent extraction supports the 
contention that electrostatic bonds, multiple van der 
T7aal*s bonds, or hydrogen bonds and not covalent bonds 
are involved in the formation of the receptor complex, 
although covalent bond formation has been shown to occur 
in some rather rare instances. Examples of such cages 
are the interaction of the organic phosphate esters 
with cholinesterase, the irreversible blockade produced
by the |3-halo ethylamines, ^  the alkylation of cell 
constituents by ethyl eneimines and the nitrogen and 
sulphur mustards,  ^ and the interaction of arsenoxid.es, 
heavy metals, iodoacetic acid and alloxan with 
sulphydryl groups to form covalent linkages.
Although little is known of the intimate physical
nature of drug receptors, attempts have been made to
deduce their shape and electric charge distribution from
con sidérations of the charge characteristics and
molecular geometry of certain biologically active
molecules, based on the assumption that the receptor
will have shape and charges complementary to those of
0
the most active species.
"Where such an approach is made using non-rigid 
molecules which are capable of existing in an infinite 
number of conformations, the conclusions are at best 
only rough approximations, as there is no reason to 
suppose that the thermodynamically most stable 
conformation of the isolated molecule is that actually 
adopted during complex formation with the receptor.
Where rigid molecules have been employed, a more accurate 
picture of the receptor is to be anticipated. An example 
of the approach using a rigid molecule is afforded by
the 7/ork of Beckett on the nature of the receptor sites
q
involved in analgesia.^
Many biologists have now come to regard a 
receptor as a volume in space defined by the surfaces- 
of enzymes, co-enzymes, and metallic ions, and so think 
of drugs as exerting their actions primarily on enzyme 
systems. V/hile it has been undisputedly established 
that certain drugs do interfere v^ ith specific enzymes, 
it is dangerous to create: the generalisation that all 
drugs necessarily do so. The intimate mode of action 
of many drugs is still unknoTm and some may act by 
merely altering membrane permeabilities by processes 
that do not involve enzymes. For instance, the mode of 
action of n euromuscular-bioeking agents is thought to 
involve changes in the electrical potential and the 
permeability properties of the end-plate region of the 
muscle membrane by a non-enzymatic process.
E . Metabolite Displacement Theory.
The concept of metabolite displacement^^ contends 
that certain compounds which possess chemical structure 
and physical properties similar to those of an ’’essential 
metabolite” of the organism, will, by virtue of these 
similarities, possess a degree of affinity for the
10
receptor sites at which the metabolite is believed to 
initiate certain fundamental processes. Originally, 
the concept v/as applied only to the phenomenon of
competitive inhibition, where the analogue was itself
without positive biological activity, but by competing 
reversibly with the natural metabolite for the available 
receptors, it was able to prevent this metabolite from 
fulfilling its normal function. The phenom.enon was 
accordingly termed ”biological antagonism” .
More recently, however, the concept has been
12extended to include cases where the analogue is
itself able to elicit a response, a measure of its
ability to do so being termed its intrinsic activity.
It has also been extended to cases where the anti­
metabolite combines irreversibly with the receptors.
Antimetabolites are of great interest to the 
experimental biochemist as they provide a useful means 
of studying the metabolic pathways of the substance 
they antagonise, and so contribute to the elucidation
15
of the routes of bio synthes i s. They are also of value 
in demonstrating previously unsuspected functions of 
well recognised metabolites, and are useful as specific 
inhibitors of selected enzymes. Again, they are of
X X
interest to the chemotherapist as they offer a possible 
means of controlling certain pathological processes 
with the additional advantage that a ready antidote, 
the metabolite itself, is always available. The early 
hopes that potent antibacterial drugs could be prepared 
by suitable alterations in the chemical structure of 
an essential growth factor of the organism have in 
general, however, not been realised as the antimetabolite 
must meet the additional requirement of showing a 
much higher selectivity of action against the micro­
organism than against the tissues of the patient.
An example of a series of antimetabolites which do 
meet this additional requirement is provided by the 
pantothenic acid analogues used as antimalarials which
do not elicit signs of vitamin deficiency in higher
15animals but do so in micro-organisms.
The intentional design of compounds capable 
of acting as metabolite-displacing agents is now a 
well established procedure. The molecules of such compounds 
must necessarily bear considerable resemblance to 
those of the compounds which they are designed to 
displace and are usually related to them by such 
processes as substitution, homologation, and isomérisation.
Such analogues can be reasonably expected to intensify, 
mimic, or oppose the biological action of the natural 
metabolite depending upon their affinities for the 
receptor and upon their intrinsic activities.
The situation is, however, complicated by the 
fact that at least three sites may be involved in the 
biological history of the natural metabolite, and the 
analogue could conceivably act as a displacing agent 
at any one of these sites or at any combination of them. 
The physical and geometrical properties of each of these 
sites are probably very similar since all are normally 
concerned in complex-formation with the same molecular 
species. Firstly there is the binding site which may 
also be involved in the synthesis of the natural 
metabolite, and the analogue could act by releasing 
the metabolite from its bound inactive form. Indeed, 
certain drugs are known which release such compounds as 
5-hydroxytryptamine, adrenaline, and histamine from 
their binding sites. Secondly there is the receptor 
site proper at which the metabolite initiates its 
characteristic train of events and which has already 
been discussed. Thirdly there is the site at v/hich 
the metabolite is d estro ted. In some cases, this may be
the receptor site itself, hut in other cases it would 
appear to he physically distinct from it - as, for 
example, in the destruction of acet^/lcholine at the 
neuromuscular junction where the enzyme ac etyl- 
c hoi in esterase hydrol.yses the neurohormone so that its 
effect is not exerted indefi n i t e l y . Anti-cholinestera se 
drugs act preventing the degradation of acetyl­
choline, and it is conceivable that c er tain metabolite 
analogues could also act \ )y inhibiting the inactivation 
of the natuTcal metabo li te .
Hh er e s. ph y siolo g i c al I3/ a. c t iv e sub stance h a s 
more than one site of action, it is possible that the
receptors invoIved in each case may be somewhat
different in charac t e r . For instance, it ha.s been 
postulated that there are two types of receptor for 
adrenaline, and these have been designated the oL and 
adrenotrophic receptors.^^ There are also i.ndications 
that the receptors for 5 - h 37 d r o x 3/' t r y p t am in e in the 
central nervous s3^stem a.re of a somewhat different 
na ture from those involved in the s timula tion of 
smooth m u s c l e . ”*^ Such variations in the nature of the
receptors could create different values for the
intrinsic activity and the affinit 3^  of the antimetabolite
X 4-
at each site. The antimetabolite could then reasonably 
be expected to show quite different actions at the 
various sites. For example, it might mimic its natural 
analogue at one site, inhibit it at another, and be 
totally without effect at a third.
It must always be borne in mind that a new compound, 
designed as an analogue of a specific metabolite^ might 
exert a completely unexpected biological action due 
to its ability to act at a totally different set of 
receptors in the organism. Such a situation arose in 
the case of the thiambutenes. These compounds which 
possess marked analgesic properties were originally 
prepared as potential atropinic, antihistaminic, 
and local anaesthetic agents on account of their close 
relationship to the J,J-diphenylallylamines.
0 . Bio iso sterism.
One particularly successful approach used to 
prepare new m etabolit e-d isplacing agents is the synthesis 
of compounds bearing an isosteric relationship to an 
essential metabolite. The original concept of isosterism, 
first introduced by Langmuir^^ to express the similarity 
of physical properties of simple molecules such as 
carbon monoxide and nitrogen which have identical
c' :Q N* :N
O
V
H VII
VI
electronic arrangements in the outer or valency 
shell (as portrayed in the classical manner in figures
I and II respectively), has been extended by other 
19workers to include larger molecules v;hose peripheral 
layers of electrons are identical. Thus, benzene (III), 
pyridine (IV), furan (V), pyrrole (VI), and thiophen 
(VII), each with its é Tf electrons, are considered as 
being isosteric.
The physical and chemical properties of these 
five isosteres have long been recognised as being very 
similar, and it is therefore not surprising that in the 
case of biologically active compounds possessing one 
of these rings, considerable attention has been paid 
to the preparation of isosteres in which this ring has 
been replaced by one of the others'.
Not only will isosteres possess similar electronic 
arrangements but they will also usually have similar 
overall electric fields, similar geometric properties, 
and molecular weights of the same order of magnitude.
Hence it is to be expected that variations in physico­
chemical properties will be minimised, although not 
eliminated, enabling a somewhat limited comparison of 
changes in biological activity with changes in chemical
s truc tur e to be made. The idea that isosteres should
possess similar biological properties to those of
their natural analogues is inherent in the terra
20”bioisosterism” introduced by Friedman. This term
covers the case where an i so st ere opposes the action
of the natural metabolite as well as that where it
mimics or intensifies it, for as has already been
mentioned these different actions depend solely upon
the intrinsic activity and the affinity of the i so st er e
for the receptors.
Many thiophen isosteres of biologically active
molecules possessing benzene rings have been prepared
21and tested, and several reviews are available
22including one prepared especially as background 
ma ter ia.l for this work and which is included in this 
thesis as appendix I.
Scant attention has been paid, however, to 
the isosteric replacement of pyrrole rings by thiophen 
rings in molecules of biologically active compounds.
In particular, little work has been done on the study 
of isosteres of indole derivatives- which as a class 
represent a group of considerable biological interest.
It was therefore deemed worthwhile to prepare thionaphthen
V II I IX
CO^H
XI
XII
HO
XIII
isosteres of some of the simpler indole compounds. In 
Orel er that this work may be seen in its correct 
perspective, a brief summary of the biological importance 
of indole derivatives is given followed b]/ an account 
of the thionaphthen isosteres already reported.
IT Biological Activity in Compounds Possessing the 
Indole Nucleus.
The indole nucleus (VIIl) and the related 
indoline or 2,J-dihydroindole nucleus (IX) occur in 
the molecules of a large number of natural products 
many of which are of pharmacological importance. These 
indole and indoline derivatives exhibit a v/ide range of 
chemical complexity from the simple alkaloid gramine 
and the essential amino-acid tryptophan on the one hand 
to th. e c:{ ti'cmel}" complex alkaloids of calabash curare 
on the other.
The parent compound indole is itself without 
great biological significance but it has been reported^^ 
to affect the motor elements of the spinal cord in 
rabbits and mice.
Like all other essential amino-acids, tryptophan (X)
which is regarded as the biogenetic precursor of the 
naturally occurring indole derivatives', is without 
pharmacological action, but the related decarboxylation 
product tryptamine (XI), in common with other proteinogenic 
amines such as histamine, dopamine, and tyramine 
possesses pharmacological activity. Tryptamine is a
weak pressor agent, exerting its effect by a nicotine-
25
like mode of action. It has also been shown to exert
a stimulant action on the mammalian heart and respiratory
r e c e p t o r s , b u t  the latter finding is complicated by
the fact that tryptamine is known to procure the
27
release of histamine.
5-Hydroxytryptophan (XII) is of considerable
interest as it can readily cross the blood-brain
barrier, and undergo _in vivo decarboxylation into
5-hydroxytryptamine (XIII) in the central nervous 
2 8system, whereas ^-hydroxytryptamine is itself 
virtually unable to penetrate this barrier.
5-Hydroxytryptamine (syn. serotonin or enteramine) 
is of considerable interest to the animal physiologist.
It occurs predominantly in the central and peripheral 
nervous s y s t e m s , t h e  blood p l a t e l e t s , a n d  in the
51en ter o chroma ff in cells of the gastro-int estinal tract.
5 -Hjdroxytryptamine has a stimu]ant action on 
smooth muscle^^ and it exhibits both hyper- and hypo-
tensive actions in the cat, dog, and m a n . It has been
claimed to produce con strict ion of the renal vascular 
beds with cons p^ cu on t antid iur esi s , a.nd this action has 
been suggested a? a physiolopica1 role of the c o m p o u n d .^
It has also been suggested that it may function as a 
local hormone involved in gastro-intestinal motility.
5 -h 3"d ro xytrypta min e has been po s tul a t ed to be involved 
in stress,'^' and it has bp en shown to be a notent oa. in - 
r o d u c in g a g en t in th e bl i s t er t e s t . ^
'^ h e greatest interest in ^“Hydrox}/trg^ptamin e, 
h 017'ever, is in its rol e in the c entrai nervous system, and
it is of e.ytreme impor tanc e from the psychopha rmacologi ca 1
uoint of view. It is known to be released from its
bound f o rm in the b r a i n un d er th e in f lu en c e of th e
tranguillising alkaloids of Rauwolfia,' and by the 
analeptic drug amphetamine.'' The exact function of 
5 -hydroxytryptamine in t h e brain is, h o w e v e r , by no
means clear. Direct injection of the compound into
til e la.teral ventricles of the cat has been s h o m  to 
wroduce lethargy, anxiety, and muscular we^kn ess 
to o ether y w, th an ability to maintain strann-e bo d
üp o s t u r e s  r e n i i n t s c e n t  o f  t h o s e  m a i n t a i n e d  b y  c a t s . t o n i c
2 0
r c h i z o p h r e n i c s . ' I n t r a v e n t r i c u l a r  i n j e c t i o n  o f
5 “ h ^ / d r o x y t r y p t s . m i . n e  a l s o  p r o l o n g s  b a r b i t u r a t e  s l e e p i n g  
t i m  e . ^
F r e e  ^ i s d e s t r o y e d  in t h e
o r g p a n i s m  b y  m o n o a m i n e  o x i d a.se, 5 “ H y d r o x y / - - i n c o  1 e 
a c e t i c  a c i d  b e i n g  o n. e o f  tli e e n d  p r o d . u c t s .  A s  W o o  11 e y  
a n d  gha.T- h a v e  p r o d u c e d  e v i d e n c e ^ '  to s h o w  tha. t s o m e  
m e n t a l  d 1 sord:ers m a y  a r i s e  f r o m  a d e f i c i e n c y  o f  
p - h j W ’r o x y  t r y p t a r n i n  e ., a i i t e m p t s  h a v e  b e e n  m a d e  to i n c r e a . s e  
t h e  c o n e  en tr a tio n oi fre»^ 5 “ '" b ^ ^ o r y  tr y p  t a m i n  e i.n t h e  b r a i n  
b v  in hi, b i 1 1 r* g i t ?  d n s t r n o t i o n  bp' o n o a m i r e o x i d a s e
7 n
■^’h. th i pron i s 7 i. d . - "
T h e  ^ a c c u m u l a t e d  f a c t s  a n d  t h e o r i e s  c o n c e r n i n g
I'Proxy t r y p t a r n i n  0 u - Y p  b n e n  t h e  s u b j e c t  o f  s e v e r a l  
h 0
r e v i e w s ,  a n d  a n  e x c e l l e n t  a c c o u n t  o f  i t s  b i o c h e m i s t r y  
a n d  b i o g e n e s i s  ha.ss r e c e n t l y  a p p e a r  e d . I t  i s  i n t e r e s t i n g  
to n o t e  t o o  tha.t r e c e n t l y  th e r e  h a v e  b e e n  s p e c u l a . t  i o n  s
tha, ii r ^  1 r- t ed o r  t h o - d i. h p d r o x y  i. n d o 1 a. ]. y y 1. a m i n e s  h a v e
h 9 5
TJhy s ic l o  g i oa i. fu.ncti.o^s in i n s e c t s  " a n d  c r u s t a . c e a .  '
H a n y  s i m p l e  s y n t h e t i c  i n d o l e  dériva, t i v  es h a v e
b e e n  p r e p a r e d ,  a s  p o t e n t i a l  an ti '^ t,a b o l i  t e s  o f  y-bg/droxp/- 
*17 4445 4
t r]ap ta.ri i n e . ‘ ' '"hese c o m p o u n d s  h a v e  u s u a . l l y  b e e n
CH CH.O N ^
XIV XV
CH n ;
XVI
2 "C H
XVII
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derivatives of tryptamine or gramine, and a number do
indeed effectively antagonise the action of ^-hydroxy-
tryptamine on smooth muscle. Some of the compounds
also have psycho tomimetic action. It is of considerable
theoretical interest that these synthetic derivatives
may show different activities on different preparations
or on the same preparation when administered in
different coneentrations. Thus, J-ethyl-2-methyl-
^-nitroindole (XIV) opposes the pressor action of
5-hydroxytryptamine in the dog, but mimics the action
47
of 5-hydroxytryptamine on the clam heart, ' and 
5-dimethylamino-ethyl-2-methylindole (X7 ) inhibits 
the action of 5-hydroxytryptamine on the rat uterus, 
but will itself produce contractions at slightly 
higher concentrations. These examples can be interpreted 
as showing that the nature of the 5“hydroxytryptamine 
receptor site varies in the different tissues and this 
is reflected in differences in the affinities and 
intrinsic activities of the pharmacon. Indeed, Gaddum 
has postulated^^ that at least two distinct types 
of 5-hydroxytryptamine receptor exist.
Other simple synthetic antagonists of 5-hydroxy- 
tryptamine worthy of mention are 5-®-mino-2-methylgramine
(XVI),^^ 4-carbomethoxygramine (XVIl),^^ and 1-benzyl-
2-methyl-5-methoxytryptaraine (XVIII) which is a potent
peripheral antagonist of 5-hydroxytryptamine and has
47,49
been used as an antihypertensive agent. It
appears to have no central effects unless given
intraventricularly.
Certain more complex indole derivatives also
appear to be able to antagonise 5-hydroxytryptamine.
Of these, lysergic acid diethylamide and 2-bromolysergic
acid diethylamide are the most important. Lysergic
50acid diethylamide is a potent hallucinogen and is 
also a potent antagonist of the action of 5-hyd.roxy-
51tryptamine on smooth muscle. 2-Bromolysergic acid 
diethylamid-e on the other hand does not readily 
produce mental changes in man, but it is even more 
potent than lysergic acid diethylamide as an antagonist
52
of the peripheral actions of 5-hydroxytryptamine.
These facts would, seem to be adequately explained on 
the basis of the different receptors involved being 
such as to create different affinities and intrinsic 
activities in the bromo derivative with respect to the 
two sites of action.
The role of lysergic acid diethylamide in the
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production of mental disturbances has been well 
reviewed by Rothlin. Many other lysergic acid 
derivatives also antagonise ^-hydroxytryptaraine.
Recent work $ however, would tend to show that the 
psychological effects of lysergic acid diethylamide 
do not result from a simple antagonism to ^-hydroxy-
55tryptamine.
Yet other indole derivatives have been synthesised
and tested, not for their ability to antagonise the
8 c tions of 5-hydroxytryptamine, but for their ability
to inhibit the biogenesis and degradation of 5-hydroxy-
tryptamine in the body. Prominant amongst these are
56
various oxinâ.ole derivatives which proved to inhibit 
the action of monoamine oxidase. ^-^Y'^.roxyoxindole- 
J-DL-alanine (XIX) is noteworthy in that it produces 
an vitro inhibition of 5-^y^^roxytryptamine 
decarboxylase.
Ability to mimic the actions of 5-hydroxy- 
tryptamine or to interfere with its normal metabolism 
is not confined to synthetic indole derivatives. Many 
naturally occurring indole derivatives also appear to 
share these properties. For instance, bufotenine (XX) 
which occurs both in Piptadinia perigrina (long used in
the form of Coho ha snuff in religious rite.? by some 
Am er i c A n Indian cult?) and in the skin gland? and. 
venom of tends, nro due e ? bronchoconstriction similar
c 7
to tha.t produced b^ ' 5-h yd roxytro'u tarn in e ' It also
q 8
produces central nervous ,sy?ten effects in monkeys,"'^ 
and on intravenous i.njection into man it nr o due es 
hs.ll.uc inogen ic effects .similar to those brought about 
by mescaline a,nd ly? ergic acid die thy 1 - am i d e although
the onset of activity is more rapid and the duration of
17action shorter,' '
Another psychotominetic indole a3.ka.loid is 
psilocybin ( X X I ) .^m^ .ich is obtained from the Mexican
CO
T'lr.shroom Psilocybe m Axicf^na^  ^ and which is also stated
to po s s e s s si ight syrnpa thorn ira otic a c t i vi ty . ^ In thi?
connection it mag^  be noted that there are s ev eral 
observations pointing to a similarity in the nature 
of the receptor sites for 5-hyd ro x y tr tarn in e and 
rS d r .Q1 in 6 . por example, yob imbi.n e is both an adrenergic 
bio ck in g p- g en t n d o po t en t 5 - h yd ro xy tryp tam i n e 
an t.':' g on i s t , a n d the s tri^  c tur a 1 1 y related alpt^l.oid 
r oser pi. ne i. s 3: r* o a-n to di.splace f - ' -1' d r o x y t r y p t am in. e 
from it? bind i.n g s i t e s . 8 imil.- r l2 , the polypeptide 
ergot alboloi.ds are antagonists of both adrenaline
XXIII
CH (O
CH.
XXIV
CH.
XXV
n .
N--''*k^ sî^ (CH2)x-Ne RI K
R
XXVI
H
XXVII XXVIII
é4
pressor activity and of the peripheral actions of 
^-hydroxytryptamine, v.hilst the simple amide ergonovine 
shows greater potency against ^-hydroxytryptamine 
than against adrenaline.  ^ The related lysergic acid 
diethylamide, as well as being a potent inhibitor of 
^-hydroxytryptamine, possesses adrenergic blocking activity 
in addition to some sympathomimetic properties• ^^
Ibogaine (XXII), the principal alkaloid of 
Tabernanthe iboga Bâillon, is a central nervous 
system stimulant^^ and a mild hallucinogen,^^ and 
so this compound too raa;y interfere with the normal 
metabolism of ^-hydroxytryptamine* A more general 
study of its pharmacological actions was made by 
Paymond-Hamet and Pothlin.^^
The alkaloids harmaiine (XXIII) and harmine (XXIV),
71 72which have been isolated from the seeds and roots
47
of Peganurn harmala L., also antagonise 5*hydroxytryptamine*
7dOther investigations  ^ of the pharmacological actions 
of these alkaloids have shown that they possess 
coronary-dilator, cardio toxic, oxytocic, convulsant 
and muscle relaxant properties which are pualitatively 
similar in the case of harmine, harmaline, and tetrahydro- 
norharman. Harman (XXV) potentiates the hypertensive
XXIX
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effects of adrenaline, while harman methe sulphate 
in combination with adrenaline produces ventricular 
fibrillation in cats and dogs under pentobarbitone
75anaesthesia. Harmine and harmaline produce tremor
V é
in experimental animals.
It has been suggested that the harmala alkaloids 
act by uncoupling oxidative phosphorylation.
A series of synthetic harmol ethers were found 
to possess amoebicidal activity.Compounds of type
79
XXVI have been shown to possess hypotensive properties,  ^
and in the patent literature there is a claim that
compounds of type XXVII possess trannuillising
_  80 ac tivity.
A structure closely allied to harman is carbazole
(XXVIII), and various carbazole derivatives are claimed
81
to possess powerful local anaesthetic activity.
Pharmacological interest in the naturally 
occurring indole compounds is by no means confined to 
those which have the ability to interfere with the 
normal functioning of ^-^X^roxytryptamine.
One particularly interesting simple indole 
derivative is J-indole acetic acid (XXIX) which is 
an auxin or plant growth hormone.
^ (
The sinpl. est true indole alkaloid is g ram in e
8 8
(XXX) which occurs in sur on ting barley and in the
B d
leaves of AruT^.do don.ex . ' C-ramine ha s a pressor .action
but it wouId not apne.ar to be truly sympathomimetic
a. s it «x^^rts no action on the pupil of the r a b b i t ’s
eye/'"^ Tn general, it stimula teo s^'^ooth muscle, but
the tonus and movements of the rabbit intestine are 
84
inhibited.’ ' Large doses of grami.ne produce clonic
2 é 8 8
convul siori s .and stimula.tion of the respi.ratory centre.”’"'
Xra.rnine i ^  also claimed to lia.ve a feeble paras y m pa th o -
8 8'cimet ic action. "
Apart from the synthetic derivatives of gramine 
which behave as 5 2" ^ n o x 1 r y t a m i n e an ta.gon i s t s, others
have p r o v e d  to be oxy to c i c s a n  d local ans e s th e t ic s . ^
A series of eus ternary ammonium salts derived from
gramine have been prepared, for testing as neuromuscular
8 8blocking agents"' on account of their relationship 
as model compounds to the then postulated structure 
of the cala.ba, sh cu rare allzaloid., C-curar in e I chloride. 
Various eua.t ernar y jï an d g - ca rbol in e d er i va t iv e:;s (XXXl) of 
gramine have also been prepared, and tested for neuro-
go
muscular blocking activity. Other nuaternary salts 
have been reported including the gramine derivative of
^NCH.
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An important group of indole alkaloids occurs 
in ergot, the sclerotium of the fungus G1aviceps 
purpurea which grows parasitically on the pistils of 
many grasses and cereals, especially rye. The extremely 
poisonous nature of ergot has long been recognised 
and the ergot alkaloids have been the subject of 
several reviews ^ '9  ^Actually, two series of indole 
alkaloids occur in ergot. The pharmacologically active 
alkaloids are all laevorotatory and are derivatives 
of lysergic acid (XXXIII), several synthetic derivatives 
of which have already been mentioned. The dextro­
rotatory alkaloids are derivatives of isolysergic acid 
which is the C-8 epimer of lysergic acid.
The most important ergot alkaloids from the
biological point of view are ergotamine, ergocornine,
ergocristine, ergokryptine, and ergonovine (syn.
ergometrine). The first four, which are all complex
polypeptide derivatives of lysergic acid, possess
adrenergic blocking activity, an action even more
92pronounced in their ^,10-dihydro derivatives.'
In addition to their adrenergic blocking 
properties, the polypeptide alkaloids also show- 
similar iti es to adrenaline at certain receptors and
produce an intense peripheral vasoconstriction which 
is responsible for the gangrene characteristic of 
severe ergot poisoning. They also stimulate smooth
65muscle and exert a complex action on the central
nervous system. }^rgotamine can be effective in relieving
migraine, but the mechanism of action is obscure.
Prgonovine, the simplest of the ergot alkaloids,
is the amide of lysergic acid and 2-aminopropanol. It
has pronounced oxytocic activity and was at one time
used to quicken child-birth. This use however led to
many still-births and to-day ergonovine is employed only
to control po s t-par turn haemorrhage.
The Chinese drug %Vu Chu Yu, formerly used as a
stimulant, carminative, deobstruent, stomachic,
9 5
astringent, and anthelmintic remedy,^ consists of the
dried fruit of Evodia ruta ecarna. Hook f. and Thoms,
and has been shovm to contain the indole alkaloids
94
evodiamine (XXXIV) and rutaecarpine (XXXV) . Because 
of the structural similarity, the pharmacological 
properties of evodiamine and rutaecarpine were compared 
with those of yohimbine, and they were showTi to increase 
the arterial blood pressure. They do not, however, have 
the adrenergic blocking action of yohimbine.
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The alkaloid yohimhine (XXXVI), obtained from 
the bark of Panainyatalia yohimba Pierre * (syn.
Corynanthe yohimbe K.Schum) a tree indigenous to the 
Cameroons and the French Congo, possesses a variety 
of pharmacological actions including in addition to 
its anti-5-hydroxytryptamine activity already mentioned, 
anaesthetic activity. It opposes the action of adrenailine 
and its vasodilator activity is particularly pronounced 
in the genital organs, the resulting stimulation 
leading to its use as an aphrodisiac in veterinary 
pr ac tic e•
95The related alkaloid sarpegine (XXXVII) is
9éalso an adrenergic blocking agent, and ajmalicine 
(XXXVIII) has adrenergic blocking properties equal in 
potency to those of the dihydro ergo t alkaloids.
Several 1"/-alkylaminoyohimbans have been prepared
97
as potential hypotensives.
Other complex indole alkaloids are found in 
various species of Ppu-f^ oI f 1 a . Heserpine ( XXXIX) and 
rescinnamine are of interest on account of their 
tranquill ising properties and hypotensive action.
As previously mentioned, these alkaloids also possess 
the ability to release 5"^y^-^oxytryptamine both in the
"brain and from the blood platelets.
The hypotensive effects are mediated by the 
action of the alkaloids on the autonomic nervous 
system. They produce an increase in tonic parasympathetic 
activity and a decrease in tonic sympathetic activity 
of the cardiovascular and gas tro-in te st inal systems,
giving a fall in blood pressure and increased gastro-
9 é , 9 8intestinal motility."^ Various simple gramine and
tryptamine models of the Bauwolfia alkaloids have been
99pr epared, and various reserpine analogues including
lS-0-(5,4,5“trimethoxybenzoyl)-reserpic acid have also
been prepared in the search for enhanced sedative or
, . 4.. 100hypotensive activity.
The indol ine derivative;, ajmaline (XL) wh i ch occurs
wi th reserpine and rescinnamine in nature is without
sedative^^ or hypo tensive^^^ action, and in large doses
actually has a pressor action.
Although the maj ority of the Cinchona alkaloids
are ouinoline derivatives, they are postulated to arise
102in nature from indolic precursors, and several are 
themselves indole derivatives. One such alkaloid is 
cinchonamine (XLI) which like quinine is a general 
protoplasmic poison, has antimalarial activity, and
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e e r t p 8 X-' ^  ^^ 1 A c t i o >1 on t, h e  ^i e n r t . " It i p some
six times r toxic ?'s c u i n i n. e encl possesses pronounced
c en tr si. convulsant properties. The in<-'’ol ine er ivr?. tive
nu in G mine (XLII) has similnr "biologie a. ]. properties.
Several othei* inc^oline elValoir^s are of
c on s. i 1 cr a bl e pherme. col opical irripo r tc.n c e , These inelu(?e
the antiehol ines t erase phy so s t ipGuin e (XLIII), first
isola tel i.n 1 T 4 f non the es. la bar bean (Phy so s tigm a
V en eno sum) , and strychnine vhich to g; e th er ui th
bru. nine a. n d r sla tel a l"h a 1 o i d s occurs in the seeds of
e InPian tree Ttryoimo s jIUx vomica and nh ose structure
1 0^
( XT; lY ) W's f in a 1 Im-' s ta bl i shed b y Po o dme.r c . ' Th e
nan t action of strycTinine is to prod uc e marked
s t-ismP.a tier of tlie su inal cord. Its oh a rme.colo py is
•'•■-c 11 sn.m^ '^  a.r i s od by To d a.n sdc i _e_t a 1 ,
The structure of the indol in e alkc.loid
G s “5 i d o s ;o e r m i n, e ( Y I,Y ) has r ec en 11 y been e 1 u c i d a. t e d . ^
Th i s compound occurs in the bark of A so id o soerma.
euebr a cho b 1 anco and h<^  s been shoun to reverse the
corr s t r ic to 7- responses of the p e r f u s e d  blood vessels
o f 1dn c ra 1'bi t ’ s ear an d th e ra t h ind o u Cir t er s to 
-1 . iona r r en a 1 an e .
The a.lkaloids of Gala.ba.sh curare are uoirerful
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poisons wi th potent neuromuscular blocking activity,
and nearly all appear to be indoline derivatives.
Examples are C-fluorocurarine (XLVI) also known as
C-curarine and the dimeric toxiferine I (XLVIl).^^^
Toxiferine I has been shovm to be active in the mouse
11 5
head-drop test at dosage levels of ^yjLg. per Kg., 
and so is one of the most potent pharmacologically 
active alkaloids knovm.
Two alkaloiâs also worthy of mention although 
not strictly true incloline derivatives are gl io toxin 
and erythroidine. Cliotoxin, first isolated from the 
culture fluid of an organism believed to be Cliocle dium 
fimbriaturn but more probably Trichoderma viride, has 
been shovoi to possess the modified indol in e structure 
X L V I I I . I t  is highly bacteriostatic towards Gram 
positive bacetria and remarkably effective against
113
fungi, although too toxic to be of therapeutic value.
It has(, however, seen application against certain plant 
pathogens. ^-Erythroidine ( IL) and its dihydro- 
derivative are of interest as the tertiary bases are 
more potent as neuromuscular blocking agents than are 
their derived quaternary salts. The mechanism of action 
of the dihydro compounds has recently been shovm to 
be similar to that of d-tubocurarine.
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As mentionea previously, all the indole alkaloids
are considered to arise biogenetically from tryptophan,
and in the case of gramine, this relationship was
conclusively proved several years ago by means of the
119radioactive tracer technique. ' More recently, it
120has been shown also by radioactive tracer technique 
that tryptophan is a direct precursor of the reduced 
^-carboline nucleus of ajmaline. This observation is 
of the utmost importance as it is the first experimental 
verification of the hypothesis that tryptophan is 
involved in the biosynthesis of the complex indole 
alkalo ids.
Tables I and II show the classical schemes by
v/hich biogenesis is assumed to occur in the case of the
more complex alkaloids such as cinchonamine and
strychnine, and the ajmaline and rauwolfia types.
However, certain shortcomings in these
biogenetic schemes have been pointed out by \?enkert 
121and Bringi, who feel that the state of oxidation in 
ring 13, the absolute conf igura tion of C-I5 , and the 
origin of the carbornethoxy group in the yohimbine 
nucleus, are not fully explained by the classical
hypothesis, and they have suggested that shikimic acid
CH2C02H
LI
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NH
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R
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R= H,CH3.Ph 
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Cl
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might well replace dihyâroxyphenylalanine in the
biogenetic scheme. Support for this view comes from
the report that shikimic acid is a natural progenitor
122
of the aromatic amino-acids.
TIT Thionaohthen Iso steres of Indole Derivatives.
A s  previously stated, relatively little work 
towards the preparation of thionaphthen isosteres of 
indole compounds appears to have been recorded, so far.
J-Thionaphthen-acetic acid ( L )  was synthesised
125
from thionaphthen by Crook and. Davies, and was found 
to have much smaller growth-promoting activity than
the natura.lly occurring plant growth hormone, J-indole
124 125acetic acid. Further v/ork by Kef ford and Kelso
resulted in the syntheses of 2- 5- 5“ 67 and thionaph then
acetic acids. They reported the J-and subst i tut ed
acids to be somevdiat similar in plant-growth regulating
activity to 5-indole acetic acid, while the 2t y? and
é-isomers- hp.d the same order of activity as 2,4-dichloro-
phenoxyacetic acid.
The thionaphthen i so s tere of tryp tophan,
^-5 - thionaph thenyl-DL-alanine v/as shoim to
■^ o
be an effective antagonist to tryptophan in the
128micro-organism Lac tobacillus arabino sus. It was also
found to have a significant bacteriostatic action 
against S. ha emolyticus, but not to inhibit the growth
126
of S. Aureus or E. Coli. Inhibition of the root growth
of cucumber plants, proportional to the concentration
of 5-thionaphthenyl-DL-alanine, has also been reported.
The presence of the ^-carboline nucleus in a
number of alkaloids inspired Herz to investigate
related thionaphthen compounds as potentially active 
1 7 0
agents. Thus, he prepared the barman analogue (LIl)
via 5“(2’-amino ethyl)-thionaphthen (LIIl), the thionaphthen
i so s tere of tryptamine. The syntheses of thionaphtheno-
( 2 , J-G ) pyridine ( I,IV) and certain derivatives have also
been reported. ^
8-Aminothionaphthen, like 2-naphthylamine,
182i s reported " to inhibit the growth of the tubercle 
bac illus.
Certain thionaphthen isosteres of carcinogenic
15 8indole derivatives have been prepared. Preliminary 
experiments suggest that some of these thionsphthindoles 
may possess growth-inhibitory action on experimental 
tumours. Halogen substituted thiophen-carbazoles, for
example ^ *-chloro-J’,2^51 ,2-thiophen-carbazole (LV), 
have also been reported as potential carcinogens.
Apart from these derivatives bearing an 
isosteric relationship to biologically active indole 
derivatives, other thionaphthen compounds have been
prepared and tested in their own right. These include
184 185thionaphthen and dibenzothiophen ' which are
pes ticid es , Y-thionaph thenquinone - the
1 86
i so st ere of menadione,  ^ the thioph en analogue of
8-d eoxyequilenin,^ a n d  certain ^-haloethylamine 
derivatives of thionaphthen of the dibenamine type. 153
IV Ob.iect of Research.
The object of this thesis, therefore, was to 
continue the syntheses of thionaphthen isosteres of 
biologically active indole compounds, and, in particular 
those Y'hich might be expected to complex with the 
receptors for 8-hydroxytryptarnine, as these compounds 
might well shed more light on the physiological 
significance of this compound. Particular attention 
was paid to thionaphthen derivatives possessing 
substituents in the 5“ and 6-positions as the presence
of A n oxygenated function in ei. th er or both of these 
positions In the natural indoles is common, and would, 
seam to play an inroorta.nt In’.ological role.
The introduction of substi.tuents into the 
8 - s i tion of the th ion anh then ring system necessitated 
a,n investiga tion of orientation effects. These are 
discussed in section 1.
Section ? is concerned, with the nreparstion 
of isosteres of gra.mine derivatives as potential 
antagonists of both 8-hyd r oxy tr yr) tam in e and adrena], ine, 
pni d section 8 foals with the attempted synthesis of
8-(2’-amino ethyl)-8-hydroxythionaphthen and the syn th e s es 
of related comnound c.
Sec tion 1 .
Orientati'^n s tu die s  in S - Sn b p t i tn t pd
mb ion a ■mh 11 An D p r i va t i ves .
XLVIII
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Because all five of the unsuhstituted positions 
in 5-substitut ed thionaphth ens , yrh ere the substituent 
is a group capable of electron donation, are theoretical1 
activated in varying degrees toward s electrophilic 
attack (IjYI to LX) , a study was made of the influence 
of variation in the substituent upon the position 
taken by the entering group. The feasibility of using 
various protecting groups in the proposed syntheses 
of the compounds described in sections 2 and J could 
then be evaluated.
Previous investigations have shown that for a
strongly electron-donating group in the ^-po sition,
the order of importance of the activating influences is
LVI ^  LVII > LVIII ^ LIX >LX . Thus, ^-amino- and ^-hydroxy- 
1 59thionaphthen  ^ and the corresponding 2-carboxy 
derivatives^^^ are knovm to undergo monobromination in 
the 4-position. Although $-ao etamido thionaph th en and 
5~ac6tamidothionaphthen-2-carboxylic acid also suffer 
electrophilic attack in the 4-position, bromination of 
^-ac etoX y thionaphth en is known to take place in the 
5- p o s i t i o n . I t  is thus apparent that the difference 
in the ability of the acetemido and acetoxy groups to 
release electrons is sufficient to allow a chahge fron
the predominance of activating influence LYI to that
of activating influence LVIII. Influence LVIII is the
141most powerful influence in thionaphthen itself, and
142in thionaphthen where the 5- ti tuent is
an elec tron-wi thdrawing group.
That activating influence LVII is stronger than
activating influence LVIII where there is a strongly
electron-donating substituent, despite the fact that
the transition state involves disruption of the resonance
stabilisation of the thiophen ring, is indicated by the
formation of 4,6-dibromo derivatives on further
bromination of 4-broTno-5-hyd roxy th ionaph th en and of
14 5the corresponding 2-carboxylic acid.  ^ Additions! 
evid.enc e for activation at the é-position is to be found
in the rearrangement of 4-allyl-_5-allyloxythionaphthen
/ 159to 4,6-d iallyl-5-hydroxythionaph then. ^
The evidence for concluding that the remaining
influences are in the order LVIII >  L I X L X  for subst i tut ed
thionaphthens where the substituent is strongly electron-
donating rested solely on the results of bromination
/ 14 5experiments wi th 4 , b-dibromo-^-hyd roxy thionaph then .
On further bromination in acetic acid in the absence of 
acetate ion, 4,6-d ibromo-5-hydroxythionaphthen affords
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LXI
NO2
HO
LXI I
HoN
LXIII
HO Br
LXIV
NO2
HO
LXV
Br
first the 5,4 , é-tribromo derivative and then the
?,5,4,é-tetrabromo derivative. In the presence of
acetate ion, bromination in acetic acid takes a different
course to afford derivatives of 4,^-dihydro-^-keto-
14 5thionaphthen.
In extending the knowledge of the substitution 
reactions of 5- sub s t i tu ted thionaphthens, attention 
wf) s first directed towards the nitration of certain 
55-hydroxy thionaphth ens. Under the mild conditions employed, 
tile orientation was found to be similar to that 
encountered in the bromination studies. ]?-Hyd roxy- 
thionaphthen (LXI, R = H) itself underwent mononitration 
in cold acetic acid to form ^-hydroxy-4-nitro thionaphthen 
(LXII, R = K), identical with a specimen prepared by 
an alternative synthesis from the known ^-amino-4- 
nitrothionaphthen (LXIII, R = H ),  ^^ ^ by nucleophilic 
displacement of the amino group by an hydroxyl group. 
5-hydroxythionaphthen-P-carboxylic acid (LXI, H = CO^H) 
was also found to undergo mononitration directly in 
the 4-position, the product being identical with an 
authentic sample of ^-hydroxy-4-nitro thionaph th en-2- 
carboxylic acid (LXII, R - OO^H) prepared from the 
5-amino-4-nitro acid (LXIII, R =
s imila rly, 5-bromo-5>-hyd roxy- 4-nitro th ionaph th en
(LXV) wa s obta.ined by mononi tra tion of J-bromo-^-
hy6 roxythionaph th en (LXIV) in acetic acid. The structure
of the product LXV was readily apparent from a study
of the infrared spectrum in carbon tetrachloride
solution at a dilution sufficient to ensure absence of
in t ermol ecular hydrogen bonding mg./ml.). The
-1OH stretching frequency at 525O cm. showed chelation
of the nitro and hydroxyl groups, thus proving their
ortho relationship. Reduction of this compound,
followed, by oxidation, gave the 4 ,^-quinone chare c ter i s ed
14 4by the Craven test.
'7ith excess of nitric acid, ^-bromo-^-hydroxy-
thionaph th en formed a dinitro derivative, the structure
of which has not been established.
As nitration proved to be strictly analogous
to bromination in the above cases, it was felt necessary
to reinvestigate the compound previously assigned the
145structure 4-bromo-^-hydroxy-^-nitro thionaph th en, 
and formed by the action of nitric acid on 4-bromo- 
5-hydroxythionaphthen. In vi ew of the fact that the 
latter compound affords the 4,6-dibromo derivative on 
further bromination, it seemed probable that the nitration 
product was in reality 4-bromo-^-hydroxy-^-nitro-
HO
LXVI
LXVIM
NO2Ph-C-O
LXIX
NO2
LXX
Br
NO2HO
LXVI I
O Br
LXXI
O
LXXI I
thionaphthen (LXVI). That thip was indeed the case was
readily apparent from a study of its infrared spectrum
in cs-rbon tetrachloride solution (l.l mg./ml*). The
position of the fundamental OH stretching frequency 
-1
at 5211 cm. showed that there was complete chelation 
proving the ortho relationship of the hydroxyl and 
nitro groups. The true 4-'bromo~5-hydroxy-J-nitro- 
thionaphthen (LXVII) was prepared from ^-benzoyloxy- 
thionaphthen (LXVIII) by nitration (LXIX) followed by 
hydrolysis to the free phenol (LXX), and monobromination 
in Acetic acid. The position of the Oli stretching 
frequency of the nitro phenol ( LXX ) at 80 crn .  ^ in 
carbon tetrachloride solution (1.1 mg./ml.) showed, as 
W A t o  be expected, compl.ete absence of intramolecular 
hydrogen bonding between the nitro and hydroxyl groups. 
The OH stretching frequency of 4-bromo-^-hydroxy-$-nitro 
thionaphthen (LXVII) at cm. (1.J7 mg./ml.)
showed weak intramolecular hydrogen bonding consistant 
with the ortho relationship of the hydroxyl and bromo 
func tions .
That electrophilic substitution occurs in the 
J-position in ^-ben zo 2^ loxy thionaph th en as in 8 -ac etoxy-
thionaphthen by activation LVIII was confirmed by
Br
Br
HO
Br
LXXIil
Br NO2 LXXV
LXX IV NO2
HO
LXXVI
LXXIX LXXX
H2N
BrO p
LXXVlll
T
Br
LXX VII
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monobrominf. t ion and hydrolysis to give bromo-hydro xy- 
thionaphthen.
The course of the nitration of 4-bromo-hydroxy- 
thionaphthen vjas nevertheless interesting as under the 
same experimental conditions J,4-dibromo-^-hydroxy- 
thionaphthen is hnovm to give the keto compound (LXXI)
hich can be converted to the quinone (LXXIl) by
140boiling in benzene. The formation of LXXI may be
favoured by steric considerations as the J-and 4- 
positions of thionaphthen are analogous to the peri 
positions in naphthalene, and removal of the 4-substituent 
from the plane of the ring system would afford a method 
of relieving the steric interaction with the substituent 
The action of nitric acid on 4,6-dibromo-^- 
hydroxythionaphthen (LXXIII) has also been postulated^^^ 
to give rise to a keto compound of type LXXIV as 
initial product in order to afford an explanation for 
the formation of 6-bromo thionaphthen-4,^-quinone (LXXV)
V'h en the nitration is carried out in chloroform, and 
of 6-bromo-^-hydroxy-4-nitrothionaphthen (LXXVI) when 
the reaction is carried out in acetic acid. This 
assumption has now been proved correct by the successful 
isolation of this relatively unstable keto compound.
LXXXI LXXXII
H2NO cr
Br CH3CONH
S
LXXX IV LXXXV
CH3CONH r
LXXXII!
CH3CONH
s
LXXXVI
S
LXXXV 11
I2N
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and its conversion to the 4,5-ciuinone by boiling in 
benzene as indicated by application of the Craven test.
The brominration studies already made on 
159^-amino thionaph th en were extended in order to
discover if 4,é-disubstitution occurred analogously 
to that with ^-hydroxythionaphthen. On bromination in 
acetic acid in the presence of sodium acetate, amino-
4-bromo thionaphth en (LXXVII) gave a crystalline dibromo 
compound, which was sho-wn to be amino - 4 , 6-d ibromo­
th ionaph then (LXXVIII) by an alterr a tiv e synthesis 
from d-amino - 4-bromo tVi ionaph th en-2-car boxy lie acid 
(LXXIX) in which the ^-position is deactivated towards 
electrophilic atteck bv the presence of the acid function 
in the 2-position. Bromination of this acid to give the 
dibromo derivative (LXXX), followed by decarboxylation 
via the barium salt gave ^-amino-4,ë-dibromo thionaphthen 
(LXXVIII) unambiguously.
The mono bromo derivative obtained from ^-amino-
4-nitrothionaphthen (LXXXI) must be either the é-bromo- 
(LXXXII) or the J-bromo-derivative (LXXXIIl), depending 
on how greatly the resonance interaction between the 
nitro group and the p electrons of th e amino nitrogen 
atom counteracts activating influence LYII, thus
affecting the relative importance of activating
influence LVIII. Comparison of the product with 
authentic 5-amino-5-bromo-4-nitrothionaphthen (LXXXIIl), 
synthesised from the ’•^ nov'n ^-amino-J-bromo thionaph then 
(LXXXIV) by nitration of the derived acetamido compound 
(LXXXV) followed by hydrolysis, showed the non-identity 
of the two compounds. Thus the product of bromination 
of 5 - amino - 4-nit ro th iona.ph th en must be ^-amino-6-bromo-
4-nitrothionaphthen (LXXXII).
Wh en p- a.c e tarn ido-5-bromoth ionaph th en wa s 
dissolved in a minimum amount of acetic acid and 
warmed v^ ith excess nitric ecid, an orange crystalline 
solid, separated. It exploded, violently at 180^ and was 
r el a. tiv el y in solubl e in water and. most organic solvents. 
A strong peak at 214  ^ cm.  ^ was present in the infrared 
spectrum, but there was no evidence for the presence of 
NH, OH, or carbonyl functional groups. The absence of 
any acetyl group was confirmed by a negative acetyl 
analysis. Due to the explosive nature of the compound, 
microanalytical figures for bromine and nitrogen only 
were obtained (3r, 21.8; N, 1^.I/- ) , and these are 
consistent with the molecular formula containing the 
unit (N^Br) . Two molecular formula.s are possible, viz.
43
(Br, 22.0; N, and C^H^OgBrN^S
( Br, 21.4; M, . 0/; ) . Further experimental evidence 
is obviously required before any conclusions can be 
draw regarding the structure of this interesting 
compound. Preliminary attempts to hydrolyse or reduce 
it under a variety of experimental conditions gave 
only intractable material.
Acétylation of the amino group in ^-amino-4- 
bromothionaphthen (LXXXVI) was found to change the 
orientation from the predominant 6-subs ti tution 
occurring in amino-4-bromo thionaphthen to predominant
5-substitution. The reduction in the elec tron-donating 
power of the nitrogen atom probably combined with s ter it; 
effects is such that activation LVIII now predominates 
over LVII. That the product obtained on bromination y^ as 
indeed ^-acetamido-^,4-dibromothionaphthen (LXXXVII) 
was proved, by hydrolysis of this compound to the 
corresponding amine (LXXXVIII) which y/as prepared 
unambiguously by direct monobromination of ^-amino- 
5-bromo th ionaph th en.
J-Substitution in preference to é-substitution 
w;as also found to occur on bromination of 4-bromo-^- 
methoxythionaphthen (LXXXIX) which is itself obtained
Br
Br
CH3O
LXXXIX
'“" T O "
XC xci
C^OrH
XCI I
OoN
xcni
02N v ^
1
xcv
xcvi
"both by mono brominat ion of ^-m ethoxy th ionaph th en end 
by méthylation of 4-bromo-5-hyc]roxythionaphthen • The 
bromination product of 4-bromo-^-hyd roxythionaohth en 
proved to be identical with authentic J,4-dibromo-5- 
methoxythionaphthen (XC) prepared by méthylation of 
^,4-d ibromo-^-hyd roxythionaphthen (XCI).
It ie of interest to note that bromination of
5-hydroxy-4-nitroth ionaphth en both in the presence and 
in the absence of sodium acetate gave ouinonoid material.
Trith an electron withdrawing group present in 
each ring, the thionaphthen nucleus appears so 
deactivated, as to preclude el ec troph ilic e.ttack und er 
the conditions employed. Thus, attempted bromination of
5-nitrothionaphthen-2-carboxylic acid was unsuccessful 
as vrere attempts to brominate and nitrate methyl 
^-acetoxythionaphth en-2-carboxylate in hot acetic acid. 
Nitration of 5-nitrothionaphthen-2-carboxylic acid 
in hot acetic acid in the presence of concentrated 
sulphuric acid, however, gave rise to a complex mixture 
from which two isomeric trinitrothionaphthens containing 
no carboxyl group wer e isolated in low Afield.
Presumably, decarboxylation can be attributed to 
activation by the sulphur atom as in XCII analogous
yto the activation exerted by the hydroxyl group in
the conversion of 5,5-dinitro-2-hydroxybenzoic acid.
into 2 , 4 , 6-tr ini troph end •
The sodium salt of ^-ni tro thionaph th en-2-
carboxylic acid (XCIII) has been reported to undergo
140
bromination in aqueous solution, the acid obtained
being identical with the main product from an attempted
147Hunsdiecker reaction on ^-nitro thionaphthen-2-
140carboxylic acid. This acid has now been sIiotati to be
5-bromo-^-nitrothionaphthen-2-carboxylic acid (XCIV) 
(and not T-bromo-^-nitro th ionephth en-2-carboxylic acid 
as previously suggested~^^) by decarboxylation via 
the barium salt which gave a product identical with
142an authentic sample of bromo-^-nitro thionaphthen.
The successful bromination of the sodium salt and the 
failure of the free acid to react with bromine can 
perhaps be attributed to electronic activation LVIII 
coupled with the effect of the carboxylic anion. The 
presence of the anion alone would not seem to be 
sufficient as sodium benzoate is inert under the same 
reaction conditions. Application of the Hunsdiecker 
reaction to ^-b r o m o -ni tro th ionaph then-2-carboxylic 
acid gave 2,J-dibromo-J-nitrothionaphthen (XCV),
y -A-
identical with the cl ihromoni tro compound obtained in
small yield from the Hunsdiecker reaction on ^-nitro-
140thionaphthen-2-carboxylic acid. Thus bromination 
of silver ^-nitrothionaphthen-2-carboxylate in the J- 
po si tion occurs preferentially to the normal Hunsdiecker 
reaction.
The reduction of nitro compounds to the
corresponding: amines was accomplished by the Raney-
148
nickel and hydrazine hydrate procedure. Ivhen this
method was applied to methyl J-bromo-^-nitrothionaphthen-
2-carboxylate, however, debromination occurred and
methyl 5-a.c etamido th ionaph th en-2-carboxylat e wa s
isolated after acétylation of the crude product.
Pr el iminary experiments indicated that a.l though 9“
bromoanthra.cene was reduced in yield to anthracene,
application of the reaction to g en eral aromatic
debromination was not satisfactory especially in view
149of the adequate methods already available. It is to 
be noted, however, that Raney-nickel in the absence of
hydrazine hydrate has been used to remove bromine from
1 90
_o-ter t-butyl-n-bromoph enol. "
The nature of the by-product formed together 
wi th 9-hydroxythionaph then-2-carboxylic acid, by
1 y
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application of the Bucherer reaction to ^-amino-
thionaphthen-2-carhoxylic acid has now been elucidated.
It is di-(2-carboxy-9-thionaphthenyl)amine (XCVI).
The formation of this compound by nucleophilic attack
of unchanged amine on the intermediate Bucherer complex
is readily apparent and is in accord with the well
esta.blished, exa,mples of secondary amine formation in
192the Bucherer reaction. The reason for the bright
yellow colour shown by XCVI is not so apparent. The
anion lacks this colour, and the disodium sa.lt and
solutions of the acid in pyrid^ine are nearly colourless.
In this connection, it is to be noted that ^-amino-4-
140bromo thionaphthen-2-carboxylic acid and ^-amino- 
4 , c - d ibromo th ionaph th en-2-ca^rboxyl ic acid whose 
■préparation is described above exist in both colourless 
and yeldov^ forms.
That structure XCVI is correct for the by­
product of the Bucherer reaction was established by its 
decarboxylation to the colourless 9,^ -di thionaph th enyl- 
s.mn'ne which wa.s identical with a specimen prepared 
unambiguously by b eating equal quantities of ^-amino- 
thionaphthen and amino thionaph then hydrochloride in 
a ses-led tube folio wring the conditions previously
19 ^
described for the preparation of diphenyle.mine.
Attempts to prepare the compound by way of io do­
th ion aph th en wrere unsuccessful.
The conclusions drawm regarding the influence 
of the substituent on the position of further 
substitution in the thionaphthen nucleus are summarised
in table 9. Much of this work has already been published,
19 4and a reprint is included as appendix 2.
1 a
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S e r t ton 2.
S v n t h e s i s  of the Thi on a r^hth en Analof^ue
of G r a m i n e  and Heir ted C o m p o u n d s .
In recent years, car die va scula.r disease has 
come to assume a prominent position as a cause of death 
in western Europe and North America, a.nd accordingly 
considerable time and attention are currently being 
devoted to the search for drugs capable of lowering 
high blood pressure. The efforts of the synthetic 
chemist have fallen into four main categories. The first 
is the production of agents capable of acting at the 
level of the central nervous system, the second is the 
production of agents capable of selectively blocking 
nerve impulse transmission at the level of the 
sympathetic ganglionic synapses, the third is the 
production of drugs' cs.pable of antagonising the action 
of noradrenaline at the sympathetic neuroeffector 
junction or of antagonising the direct action of 
adrenaline on the peripheral blood vessels, and the 
fourth is the production of drugs capable of interfering 
with the liberation of noradrenaline. Several drugs 
of the third class (adrenergic blocking agents) are 
available but none have the ideal properties required
159
by the clinician, and so are not in clinical use
today.
A further logical approach to the preparation
y /
of drugs of the third class is from considerations of 
the metabolite displacement concept. If a compound 
with strong specific affinity for the adrenaline or 
noradrens.line receptors but having zero intrinsic 
activity could be devised, it might well be a valuable 
anti-hyper tensive drug.
As previously mentioned, gramine has pressor 
activity^^ so it may conceivably have affinity for the 
adrenaline receptors and positive intrinsic activity. 
Aga.in, several g ram in e derivatives have affinity for 
q-hydroxytryptamine receptors, and as has been previously 
discussed, there appears to be some similarity in the 
nature of the receptors for ^-hydroxytryptarnine and 
for adrenaline.
Thu s, several aminomethylthionaphth en derivatives 
including 5-( d im.ethylaminomethyl )-thionaph then , the 
thionaphthen analogue of gramine itself, were synthesised 
for testing both as antagonists of adrenaline and of
196
9-hyd.roxytryptamine . Preliminary results on isolated 
tissues indicate that some of these agents do indeed, 
antagonise the action of adrenaline. Further work 
utilising the pA^ technicue^-^^ should show whether 
these drugs are truly competitive writh adrenaline.
XCVI I
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molecule for molecule, and application of the techniquea
1^8
so elegantly established by Ariens and his school
could be used to determine the affinities and the
intrinsic activities of these d.rugs.
Two compounds chemically similar to some of
those to be described, viz., J-C1,2 ,J,4-tetrahydro-
i sonuinolinomethyl)-thionaphthen and (isoindolino-
methyl)-thionaph then, have been reported in the patent 
] 59
literature, " ^  and do show hypotensive properties.
In view of the fact that certain gramine
nerivatives are oxytocic s, or local anaesthetics,^"^
it t."^as pls.nned to have the compounds n o w  to be described
tested for these properties as well. In ad_di tion,
several cu a ternary salts were prepared from the new
compounds for testing as neuromuscular blocking agents
8 8
as Craig and Tarbell have shown that certain 
quaternary?” gramine derivatives possess this activity.
The first group of compounds prepared were of 
general formula XCYII , where P. is dim ethyl amino, 
pyrrolidine, piperid ino, 2-methylpiperid ino, morpholino,
and cyclohexylamino.
5-Chloromethylthionaphthen (XCVIIl), obtained 
from thionaph then by the use of trioxan and, dry hydrogen
^7
l é O
chloride in acetic acid, was employed as the starting
material for the syntheses of these amines. Attempts
to react the chioromethyl compound directly with
ammonia to give J-( aminorn ethyl )-thionaph th en (C) both
in the presence and in the absence of solvent were
unsuccessful, so this compound was prepared by means of
a Gabriel reaction,^^^ in which chioromethylthionaph then
was condensed with potassium phthalimide in dimethyl- 
159formamide, and the resulting H-substituted phthalimide
(XCIX) hydrolysed to the amine (C) by the modified
1^2procedure of In g and II an sk e  ^ using hydrazine hydrate 
and hydrochloric acid.
^-(Dime thylaminomethyl)-thionaphthen (Cl) was 
urepared directly from J-( aminomethyl)-thionaphthen by 
the use of formaldehyde solution and formic acid 
employing the conditions described, by Gent and lIcKenna'  ^
for the dim éthylation of amino steroids.
The other amines, for exam%)l e ) - ( morpholino- 
rn ethyl)-thionaphthen (Oil), were prepared directly from 
5“chloromethylthionaphthen and the recuisite amine in 
toluene in the presence of excess sodamid.e by an 
analogous procedure to that previously described for 
the condensation of J-chloromethylthionaphthen with
DU
159
tetrahydroisoquinoline, ' the products being isolated
and characterised as the water soluble hydrochlorides.
The crystalline methiodides of J-Cdimethylamino-
methyl)-thionaphthen, )-(pyrrolidinomethyl)-thionaphthen,
5-( piperidinomethyl)-thionaphthen, and J-Cmorpholinomethyl)
thionaphthen were also prepared.
Because of the ready availability of substituted
140
thionaphthen-2-carboxylic acids, it was decided to
prepare several thionaphtben derivatives possessing a
5-subs ti tu en t end a substituted aminornethyl side chain
in the 2-position. As the corresponding compounds
lacking the 5- s^ T^ ^^ 'kituen t are readily available from
p, series of amides of thion aph then-2-carboxyl ic acid
lé 4
synthesised, by Goettsch and. T^iese, by way of lithium
lé5aluminium hydride reduction, it was decided not to
investigate them in this project. 2-( Aminomethyl)- 
thionaphtben is already known. ^
In particular, it seemed of interest to prepare 
a number of N-substituted 2-(aminomethyl)-thionaphthen 
derivatives possessing a hydroxyl function in the 
y-po sition to ascertain whether such compounds would 
prove to either mimic or oopose the biological actions 
of 5“^T^b‘0xy tryptamine , especially as 5“hyd roxygramine
HO
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i
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producen contre c tion of the rat’s uterus and so unlike 
most other gramine derivatives^ shows a degree of 
5“hydroxytryptamine-like actlvi ty.
The known -^h]r dr oxy thion aph then-2-ce rhoxylic 
acid proved to he a convenient starting point
for the synthesis of these derivatives. The phenolic 
group was protected by conversion into the benzyl ether 
with a view to subsequent removal by hydrogenolysi 
or acid hydrolysis. This particular protecting group 
was chosen because both d~benzyloxygramine end é-benzyloxy. 
grsmine have been reported to be -hydroxytryptamine 
antagoni sts ,» and so the intermediate benzyl ethers
could also be screened biologically. The benzyloxy- 
thionaphthen amines, s.s well as being potential 
5-hyd roxy tryptsm in e antagonists 1.n vi tro , should be able 
to penetrate the blood-brain barrier more easily than 
the zwi tt er ion ic hydroxyla.min es , and. thus be useful in 
in vivo studies. A.gain, certain substituted. ^-benzyloxy- 
indoles have been reported to have vasoconstrictor 
p r o p e r t i e s , a n d  so there appeared once more the 
possibility of finding adrenergic blocking agents 
within the series.
5-Benzyloxythionaphthen-2-carboxylic acid (CV)
^2
l é 9
was first prepared usinp the method described ' for
the conversion of 4-hydroxybenzoic acid into 4-benzyloxy-
benzoic acid by treatment wi th two equivalents of
benzyl chloride and sodium hydroxide in aqueous ethanol
to give benzyl 5-benzyloxythionaphthen-2-carboxylate
(civ) followed hy basic hydrolysis of the benzyl ester.
However, it was later found more convenient to prepare
CY via methyl 5-hyd roxythionaph then-2-carboxyla t e (CVT)
by benzylation of the phenolic hydroxyl group with
b e n z y l  chloride in the presence of sodium hydroxide
using the procedure of Cohen and D u d l e y . B a s i c
hydrolysis of the resulting product (CYIl) afforded.
^-ben zyl oxy thion aph then-2-carboxyl ic acid in yield.
The acid chloride, obtained by warming the
8 c id gently w i t h  excess thionylchloride, was condensed
with the requisite amine in pyridine to give the amide
which in turn was reduced, in ether with lithium
lé 5
aluminium hydride to the H-substituted 2-( aminomethyl)- 
5-benzyloxythionaphthen. .^ t^tempts to cleave the benzyl 
ether by hydrogenation with palladium on charcoal and 
Adam’s catp.lyst were unsuccessful. This is probably 
due to poisoning of the catalyst by the sulphur atom 
in the thiophen ring. The cleavage was effected
O o N
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suce e F, s fully, however, by gently heating the benzyl 
ether in cone en tra ted hydrochloric acid. The reaction 
scheme is shown in figures CVITI, CIX, and CX using 
the preparation of ^-hyd roxy-2-(morpholinomethyl)- 
thionaphthen (CX) as an example.
Other amines prepared by the sane proced-ure 
vrer e 2-( d in ethyl am in one thyl) - ^ -hydroxythionaphthen 
and $-hyd roxy-2-(pyrrol id inomethyl)-thionaph th en, along 
wi th the corresponding ^-benz^^loxy intermediates and 
p-benz3/loxy-2-( piper idinom ethyl ) - thion? ph th en .
As 5-amino-2-m ethylgramin e (XVI) has also been 
reported- to be a ^-hydroxytryptamine s.ntagonist, the 
present work was extended to include a series of ^-arnino- 
2-am ino me thyl thionaphtben derivatives. These v^ ere prepared, 
from 5-nl tro th ion aph then-2-cs.r boxylic acid ( CXI ) by 
treatment of the acid chloride with the requisite amine, 
for examiple morpholine, in benzene to give the required 
amide, in this case 2-(morpholinocarbonyl)-^-nitro­
th ion aph th en (CXIl). Lower yields of amide were obtained 
wbien pyridine was employed as solvent.
The nitro group in 2-( morpholinocarbonyl)
ni tro thionaph th en wa s smoothl;/ reduced by Paney-nickel
148
and. hydra.zine hydrate in ethanol to give
64
5 -r..mino-2-( morpho lino carbonyl ) - th ionaph th en ( CXIIl) . 
P:e^ "uction of the carbonyl function in this compound 
with lithium aluminium hydride to give ^-amino-2- 
(morpholinomethyl)-thionaphthen (CXIV) was achieved 
only after prolonged r efluxing in tetrahydrofuran with 
excess lithium aluminium hydride. The difficulty 
encountered in the reduction can be attributed to the 
presence of a primary amino group, and its ability to 
form insoluble complexes with lithium aluminium hydride.'  ^
Other amin e s of this series prepared by the same'
P/po c edur e w e r e p-?.mino- 2 - ( dim ethyl am inom e thyl) - thionaph th en , 
'^-amino- 2-( pyrrol id inom ethyl ) - thionaph th en , a.nd ^-amino- 
2-( pip er idinom e thy]. ) - th iona ph th en . These amines could 
not be obtained cry s tal1 in e, and proved difficult to 
characterise either as mono- or d.i-hydroch] orid es and 
h ydrobromid es . Accordingly, the IT-benzoyl derivatives 
■mere prepared for chemical characterisation.
1 a c rpr APp r ? t"! of /.nplomir
of 6 -h d r o X t r y T) t s m in e .
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The tmpo r t^nc e of obtain in r n t a. g on i p t p of
 ^-hyf roxy tryp tan in e in or er to facilitate no r e detailed
stnrîiep of its phys.iolo o;ical ,5îif;nif ica.nc e T-a a first
stressed by Gaddnm and Hame ed. ^7^ - In the search for
such a 2 en t s , the main effort has been directed tor/a rd s
the nrepa.ra.t 1 on of varions aramine and tryptamine
d er iva t iv es , several of if a ich have been mentioned
in the introduction to this thesis. Relaativel^^ little
attention has been paid to the icosteric approach,
and it no nl d a.puear tha.t only tieo i so s t er es of d-h yd i-o r y-
tryptas'ine are recorded in the literature. These are
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the bcnziminazole analogue (CXV), " and the indazole 
a n a 1. o p u e ( C XVI ) vh i c h h a. s si m i 1 a, r ph a, r ^  a, c o ]. o f i, c a 1 
nropprtips to y-hn/droxj' ti'yptaTnin e althonyh onl y i  to p- 
a s po t en t . ^
These tivo iso stores possess additional centres 
of electron density at the second, r in a nitrogen atom, 
and so d i f f e r considerably from h-hydroxytryptamine 
it self in. electric charge distribution. The ben so f uran 
or til i.onr, phthen i so s t er e vou.l. d be expected to be more 
c 1 o s e 1 3^ a^ i^n to  ^-hz'c^  roxy tryp tarn in e in this r^snact.
The ava ila.bi.lity of a further isostere for 
cornua.r i son wi th those already hno vn as ''-ell as for
D (
conpsirison vi th h-hyd roxy tr^/ptamin e itself vould 
therefore seem to he of considerable interest.
Apart from its potential ability to mimic or 
oppose the action of ^-hydroxytryptamin e at the receptor 
site, the thionaphtben analogue - (2 ^-aminoethyl)-
5 “h^ r^l r oxy th ionaph th en - might perhaps be expected to 
affect th e cone entration of 5“hydroxytryptarnine by 
inhi.biti.ng either  ^- h y d r o x y t r yn t o ph an d ecarboxylas e or 
mono am in e oxidase*
A11 nmpt s vnr e made to s%^ n the si s e this analogue, 
r,nd although the corr es pond in g benzyl ether, ( 2 ^ - amino 
ethyl)-5-benzyloxythionanhthen (CXX), was obtained, 
it r e s i s t e d  all attempts at conversion into ( 2 ’ - e.m ino- 
e thyl ) - 5-hy ^ roxi'th iona,ph th en either by hydrogenation or 
h y d r o 1 y a i s .
The route emnloyed for the synthesis of this
benzyl ether was via the hey intermediate J-bromo-
5 “hydroxy thionamph th en which was available by an eight
159,110
stage synthesis from o-chlorobenzaldehyde. '' The
initial step in the route taken from bromo-^-hydroxy- 
thionaphthen wa.s the protection of the hydroxyl group 
as the corresponding benzyl ether (CXVIl) by treatment 
wi111 benzyl chloride and anueous sodium hydroxide.
PhCHgO'
' t oS
I  CXVIl
 ✓COjH
PhCHgO
COjH
CXVIII ^
CHpOH
PhCHgO
CXXII
CXX
~ -C»0 ^ C H - C H ~ 0,
cxxni
cxxiv
T h e  resultinp; ^ - h e n r y l o x y -  b r o m o  t h i o n a p h t b e n  ( C X V Il )  
wg, s then c o n v e r t e d  into ^ - b e n z y l o x y t h i o n p . p h t h e n - J -  
c a r b o r y l l c  a c i d  (C X V I I I ) by the a c t i o n  of c a r b o n  d i o z i d e  
on the G r i y n a r d  c o m p l e x .  The t e c h n i o u e  e m p l o y e d  Ta.s 
b a s e d  on tha.t u s e d  for the c o n v e r s i o n  o f  J - b r o m o -
12^
th i o n  a p h t h e n  i n t o  t h i o n a p h  th en - ^  - ca r b o x y l  ic a c i d ,  
u t i l i s i n g  t h e  m e t h o d  o f  " e n t r a i n m en t" o r  c o n t i n u o n s  
a c  t i v a  t i o n  , ' v/hich e m p l o y s  m e t h y l  io id  e -and e x c e s s
’^ a p n e s i u m .  T h e  y i e l d  o f  ^ ^ y i h  i o n a p h  th  e n - J-
c a r b o x y l i c  aci'^ v a r i e d  f r o m  P O  to ^ O t  a c c o r d i n g  to t h e  
a o n n  t o f  rn e t h y l  i o d i d e  p r  e s e n t .
The a m i d e  of ^ - b en z y l o x y  tl'i ion a ph then - J-a. c e t ic 
a c i d  (CXIX) w a s  p r e p a r e d  d i r e c t l y  fr.Dm ^ - b e n z y l o x y -
t h i o n a ph t h. en - J - c a r bo xy 1 i c a c i d by u se o f  the A r n d t -X i s t e r t
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r é a c t i o n ” '' f o l l o v i n r  the p r o o e d n r e  e m p l o y e d  in the 
p r e Tie rati on of th e a rn i d e o f n-h omo a n i s i c  a c id , ^ 7  ^  The 
aci d  ch 1 or i due of h - b e n z y l  o.xy t h i o n a c h  th en - ^ ,-ca r box^.rl ic 
acid, obta.ined f r o m  the a c i d  by the a c t i o n  of t h i o n y l  
c h l o r i d  e , was c o n v e r t e d  into the d i a z o b e t o n e  vi th 
excess of d ia zom e than e , and the p r o d u c t  r ear .nanped to 
the a m i d e  of h - b e n z y l o x y t h i o n a r ) h t h e n - 9- a c e t i c  a c i d  ( O X I X )  
by tlie a c t i o n  of ammonia, and sil.ver n i t r a t e  s o l u t i o n  in 
d l o x a n  ,
( p ’ -Ant i e o ethyl ) - J' - b e n z y l o x y  thiona.ph th en ( GXX ) 
w a s  then o b t a i n e d  by r é d u c t i o n  of t h e  a m i d e  in e t h e r  
i til 1 i th i 11V ?. 1 11 -n ^ n irm h y  d r i de . ^
A, y a, n n ^ a 11 em n t a to h y d r o y en o 1 y s e the b en z yl 
ether w e r e  un su c e e s s f n l , and d i f f i c u l t y  was also 
en co n n  t er ed in ett prints to h y d.r o 1 y s e it to the f r e e  
p h e n o l ,  "'arm in y th c o n c e n t r a t e d  h y d r o c h l o r i c  acid - 
the m e t h o d  s u c c e s s f u l l y  e m n l o y e d  in s e c t i o n  2 of this 
t h e s i s  for a. similar r e a c t i o n  wh e n  t h e r e  was a t e r t i a r y  
r. ^ oiv, o y r o u p  p r e s e n t  in the m n 1 e c u 1 e - ya.ve an e x t r e m e l y  
small y ield of c r y s t a l l i n e  m a t e r i a l  s o l u b l e  in s o d i u m  
h 2"dro xi d e so lu. tion . A l t h o u y h  there was i n s u f f i c i e n t  
of the p r o d u c t  for cha.r a c t eri sa ti an , m a s s  n u m b e r s  of 
or,4 a.nd A7y o b t a i n e d  from m a s s s p e c tr e s c op y stu.di.es 
i n d i c a t e d  that the compormd m u s t h a v e  a m u c h  hi.yher 
vnoleci.ilar T'eiyh t than that of the e x p e c t e d  p r o d u c t .
]-‘yd r o l y  sis of the a m id e of ^ - b e n  z y lo xy -  
th i.ona.phth e n - c p tie acid (CXIX) mi th cone en tra. ted 
h y d r 0 ch 1.or i.c s cid. wa s of 1 i. t tl e va 7 u e a s th e am id e 
e roup wa s a 1 so Tip'd ro 1 y s ed to th e a.c id ; the rp a t er ia 1 
i s o 1 .a, t e d b r i n y so i.u hi e in sodium car b o n  at e s o l u t i o n
A'o o th e r s y n tli e t i c r o u t e  to J - ( 2 ^ - a rn i n o e t h y  1 ) - 
d - b  en yl  o x y t h i o n  a p h th en in v e s t i y a t e d  wa  s v i a
/u
5 ~ >3 en z y 1 o x yt h i o n a.ph th en - r - a % d eh yd.e ( GXX III). A11 em p t s 
to prepare th is al. d ch y d e b y the method, of B r o wn an d.
Subhs. Pao^’"^  ^ which involves reduction of the acid.
P r
0 h lo ri d p VO., t h 1 i t h i i.un t r i - 1 - b u t x/o y a. lurn inohyd ride i,-' • '
proceeded in low yield, and the aldehyde was not
characterised as such but converted into ^-henzprloxy- d-
( 2 ' -n i trovinyl)-th ion awh th en (CXXIY) by the action of
nitron ethane in the pr e s en c of amrnoniun acetate followiny
17 8the procedure described by Touny. ''
A1 though triis nitrovinyl compound would have
served a s a suitable in t ^ 'ro ed is. t e foi the or epa r^ tion of
7^ _ ( 9 » ~ a i n o  e tb^yl ) ~ t-b en zyl0 X2'th iona.ph tVi en h i c h  could, be
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obt.ained b]^  1. i t hiuni alum inium bp^dride reduction,' ' ’’ 
i. t offered no a ri vp u t a y e-s o v p-r th e route already/' reported 
via the amide of 8-h en z^ /l o >w;-th ionaph th en-8 - c e t ic 
aci<=i (CXIX) .
Bee a u se of th. e d i f f i cu.l t y a s s o c i a t e d wi th 
h^ .nl rol y sis of th e I' en zy^ l ether in the or es en ce of a 
primary am in o yr o u p , other routes in which the phenolic 
h^'d r 0X2^1 .croup v^ a s not protected wer e investi ya ted. .
> rox2''thiona uhth en-1-ca rbox2^1 ic acid. (CXXl) was 
obtained b}'^ acid h.2'd roly sis of 8 - b en z2^1 oxy^ th i onaph th en- 
A-carboxylic acid, and yave 8-h2'droxy-a-hydrox2^meth2^1~
th inn5nhthen (CXXTl) on lithiinn alurniniura hydride 
reduction. Although prinunry allylic alcohols are 
r euor t to he easily oxidised to the corresponding
a1 d eh y d e s hy manganese dioxide, attempts to oxidise 
d-hydroxy-d-hyd roxym ethylthionaph then and ^-h yd roxy- 
2-hydrox2methylthionaphthen, prepared hy lithium 
aluminium hydride reduction of methyl ^-hyd ro xyth ionaph th en- 
2-carhoxylate, in this Tay uere unsuccessful. The 
product v:hich had a uea.V pea.k at léyO era.  ^ in the 
Infrared indicative of carhonyl absorption Ta s contaminated
V 2L considerable amoun t of high m el t in a material from
’"hich 1.1 could not he readily separated. Alien the reaction 
T^ a s repeated in n itrom ethane and in th e presence of 
aunmonium a.cetate, a considerable darkening in colour 
associated with the formation of a n i trovinyl compound 
was observed, hut no crystalline material could be 
isolated..
A final a 11 emp t to utilise N-hromosuccinimide 
in the preparation of ^-hyd ro xyth ionaph th en-^-ald ehyd e 
followed the Procedure reported^'^^ for the conversion 
of 4 , -d im ethoxyph thyl alcohol, to 4 , h - d im e th oxyph thal- 
aid e>; yd e . mh i s wa s also un su cc es sf u i .
Attempts were ma.de to employ J-cyano-^-nitro-
HO
0 ::k . "Co,g/^ONHNHg
CXXV cxxvi
x o S-^C0 NHNHS02 
I CXXVI I
CH3
CMC
CXXVIII
HO
CXXiX
"Co CHo I ^g/^CH=CN02
|CXXXI
HOCo H OS^CH2CH2NH2 Co ÇH3g/'CHgCHNHg
cxxx CXXXII
7?
thionaphthe n , prepared from ^ - h r o m o - n  itro th ionaoh th en
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hy means of a Rosenmund-von Brann nitrile synthesis,
as an intermediate in a synthesis of the thionaphthen
anal, o^ue of 5 -h^ .rd ro xy tryptamin e , hut the extreme
resistance of the nitrile to hydrol.ysis and the difficulty
encountered in attempts to selectively reduce the
nitrile led to an e a r l y  rejection of this approach.
Although it has not been possible to obtain
2 ’-amino ethyl )-^'-hydroxy thionanh th en itself, the
8-benzyloxy derivative is r/orthy of extensive pharmacological
investigation especially on account of the interesting
results obtained with benzyloxy derivatives of certain
indole compounds and mentioned in the introduction and
in sec tion 2 .
In many cases, biologically active thiophen
comuounds substituted in the J-position have been found
to be slightly more active than the corresponding 2- 
21 2 2isomers, '* ' but, as there are several exceptions to
this rule, it va s decided to synthesise 2-(2 amino ethyl)- 
5 -h^/d ro xy thionaph th en as a possible antagonist of 
5 - hydroxytryptarnine . 2- ( 2 ' - Amino ethyl ) -8-hyd roxy- 
thionaphthen (CXXX) was synthesised from ^-hyd roxy- 
thionaphthen-2- carboxylic acid (C X X V ) via ^-hyd roxy-
thionaphthen-2- a l d ehyde (CXXVIII), obtained from the 
acid by the method of ItcFadyen and Stevens which involves 
the alhaline decomposition of a 1-acyl-2-aryl sulphonyl-
1 Q 5-
hydrazine.  ^ The use of this method avoided any 
necessity to protect the phenolic hydroxyl group.
Methyl ^-hydroxythionapht h e n -2-carboxylate was 
obtained in 79a yield by heating the acid under reflux 
in methanol in the presence of concentrated hydrochloric 
acid, and in quantitative yield, by treating the acid, 
with an excess of d i a z o m e t h a n e . The ester was converted 
into the acid hydrazide (C.XXVI) by reflu.xing with 
h yd ra z in e hydrate in methanol. Treatment of the 
acid, hydrazide with one equivalent of p-to lu ene sulphonyl 
chloride in pyridine gave l - ( ^ '-hyd roxythionaph t h e n - 2 '-yl- 
carbony]. )-2-J2-toluen esulphonyl hydraz in e ( CXXVI I) , 
s p - t o luenesulphonyl derivative of the substituted 
hydrazine being formed in preference to a derivative 
of the hydroxyl function, ^-hydroxythionaph th en-2- 
al d ehyde ( CXXV I I1 ) Y?as then obtained by the addition 
of solid potassium carbonate to a solution of the 
p- to lu. ene sulphonyl derivative in ethylene glycol at léo^.
The aldehyde was condensed wi th nitrom ethane in 
the presence of ammonium acetate^"^^ to give
d-hycrox27-2-( 2 ^-nitrovinyl)-thionat)hthen (CXXIX), and 
on reduction of this compound wi th lithium aluminium 
hy d r ide ,  ^ 2-( 2 ' - amino ethyl d -hyd roxy thionaph th en
(cxxx) was isolated and crystallised as the hydrochloride.
As various subst i tut ed Ol-m ethyl ethylamin es
including d-hyd roxy- oL-m ethyl tryp tarn in e are claimed^^^'’' 
to Inhibit monoamine oxidase, it seemed worthwhile 
t.o orepare 2-( 2 ’-aminopropyl )-^-hydroxythionaphthen ( CXXXII ) 
to disccuver mh other it would, exert a more prolonged action 
than 2-(2 ^ -amino ethyl)-^-hyd r o x ythionaphth e n . Another 
iu s tif ice. tion for preparing this compound lies in the 
fp. ct that o(-m ethyl tr yp tarn in e has been shov.n to inhibit 
the formation of h-hyd roxytryptamin e from ^-hyd roxy- 
tryntopha n by blocking the action of ^-hyd ro xytryp tophan 
n ecp r boryl? G e , and so there wa. s considered to be a.
st.rong no s sib il i ty th a t this compound might possess 
s in i 1 p.r ac t ivi ty .
Accord in gl. y , 2-( 2 ’ - amino propyl ) -hydro xy- 
thionaohthen (CXX..XII) was prepared by lithium aluminium 
h^wlride reduction of 8-hydroxy-2-( 2 ’-methyl-2*-nitrovinyl )- 
thionaphthen ( CXXX I ) , the cond.en sat ion product from, the 
r esc t ion of ^;-hyd ro xy thiona.ph then-2-a Idehyd.e with 
n i t r o e th an e . ^
EtO
CXXXIII
EtO
CHgCO^H
Etc
Etc
CXXXVI
EtO
CXXXIV
CXXXV
O H  
CH2C02Et
CHjCOjEt
NHj
CXXXVII
EtO 5 ^  NK2 H O  
CXXXVMI CXXXIX
E t O
C X L
EtO
It T'A R also decided to synthesise J-( 2 ^ - amino- 
ethyl ) -()-hyd roxyth ionaph then (CXXXIX) as this Tould form 
t)i e s ta r ting material for a synthesis of thionaphthen 
i so s ter es of the indole alkaloids harmine and h armaiin e 
as well as certain more complicated ^-methoxyindole 
alkaloids such as reserpine. lloreover, as ( 2 ' - amino-
e t hyl)-6-hydroxythionaphthen is the thionaphthen 
analogue of ^-hydroxytryptamine^ it seemed interesting 
to have it available for pharmacological i n v e s tigation. 
-liydroxytryptamine, synthesised by Stoll, is only
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^eeb1y ?ctive when compared with 5 - h y d r o x y t r y p t a m i n e .
Another interest in having é-hydroxythionaphthen
derivatives available lies in the fact that the 6-po sition
of indole alkaloids is subject to hydroxylation in 
1 87nature.
é-Tdthoxythio indoxyl ( G~ ethoxy- 1-0x0-2 , Vd.ihydro- 
thionaphthen) (CXXXIII) was employed as starting material 
for the synthesis. Thio ind.ox;/ls generally react both ss 
k etones and as phenols, forming oximes, semicarbazone s , 
ethers end sodium salts, but as attempts to condense 
the k eto function, present in thioindoxyl, with malonic 
acid under a variety of conditions have been reoorted
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to be unsuccessful,' it v/as decided to ascertain
( ^
T'hether application of the Reformatski reaction with 
ethyl hromacetate was feasible. A c c o r d i n g l y , é-ethoxy- 
thioindoxyl was heated under reflux for 4 hours in a 
mixture of benzene and. toluene with two equivalents 
of ethylbromacetate and zinc 'wool’ , and the pro due t 
hydrolysed with ethanolic sodium hydroxide solution.
The fraction soluble in sodium carbonate solution was 
separated, and from this a, 20/ yield of crystalline 
material was isolated.
The anal y tic al figures for the product w^ere 
consistant with the molecular formula C î'^0  S showing12 12 q
that dehydration of the intermediate ^ - h y d  roxy-e st er 
(CXXXiy) had. taken place. This dehydration would be 
expected to take place in such a way as to regenerate 
the fully aromatic thionaphthen nucleus (CXXXV). That 
this wa s indeed the case and that the product wa s 
é -ethoxythionaphthen-5-acetic acid (CXXXVl) was indicated 
by the compound showing an absorption maximum at 2J4 
(6 = 27,100) in the ultraviolet su ec trum similar to 
that of h-m e thi oxyth iona ph th en at 2J8 (e = 19 , 2 00 ) .
Conformiation of this structure vras provided by repeating 
the reaction with thioindoxyl itself which was prepared, 
from an th ran il ic acid b]' the knovna pro c edur e . The
i(
product of the Reformatski reaction on this compound
had identical physical constants to those of J-
12 ^
thionaphthenylacetic acid.
The success of the R e f o r m â t ski reaction thus
Provides a route to other thionaphthen analogues of
substituted tryptarnin e s , particularly as many thioindoxyls
are readil.y available as dyestuff intermediates.
As attempts to prepare the acid chloride of
6 - ethoxythionaphthen - 8-acetic acid by the action of
thionyl chloride were unsuccessful, the acid chloride
s obtained by 't^’-arming the acid gently with oxal^rl
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ehloride in dry benzene. ' The addition of excess 
a in m o n i a solution to the acid chloride gave a good yield 
of the cor r e soo nd in g amide (C.XXXYIl), and on reduction 
of the product wi th lithium aluminium hydride in ether,
^-(2 ’-aminoethyl)- é - ethoxythionaphthen (CXXXVIII) wa s 
o b ta in e d .
Finally, hyd rolysis of the ethyl ether function 
with h]^d ro brom ic acid, in acetic acid gave 5 - ( 2 ’-amino- 
ethyl)-6-hydroxythionaphthen (CXXXIX), the thionaphthen 
analogue of 6-hydroxytryptarnine.
The thionaphthen analogue of h armai in e , containing 
a 7- € th o X y group in place of the 7~^ ethoxy group nr es en t
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in the Tie tnral a l k a l o i d ,  w a s  p r e p a r e d  hy r i n g  c l o s u r e  
of the 71- a c e t y l  d e r i v a t i v e  of J - ( 2 ’ - emino e thyl )-6-
1 50ethoxythionaphth en using the method described b%/ H er z 
in his synthesis of the thionaphthen analogue of harman. 
On heating the acetyl derivative under reflux for 4 hours 
in toluene with phosphorus p e n tachloride and phosphorus 
oxychlorid e , 7 - ethoxy-1-m ethyl-5,4-d ihydro thionaphtheno- 
( 2 , 5-C)pyridine (CXL) was isolated as a crys tall in e solid 
after chroma.tography on grade J alumina. The tricyclic 
or o d u c t T^ a s characterised as th e wa ter soluble am in e 
hydrochloride ,
The c o r n e s p o n d i n g  a n a l o g u e  of h a r m i n e  itself,
7 - e t h o x y - 1- m e t h y l t h i o n a p h t h e n o ( 2 ,^ - C )pyr id in e (CXLI)
T-as o b t a i n e d  f r o m  t h i s  c o m p o u n d  by d e h y d r o g e n a t i o n  
wi th 4d a m ’ s c a t a l y s t  at 200^.
(y
Rxoerimental.
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8 - H y d r o y y - 4 - n i trot Vi i o n a ~o h t h e n ( L X II, R = H ) . -
N 1 59
5- A c etamido-4-nitrothionaphthen (2.25 R*» /*? mmoles) "^
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was dissolved in Ciai sen’ s alkali  ^ (J5 G* potassium
hydroxide in 25 ml. of water and 100 ml. of methanol) 
rnd heated under reflux for 5 h r . Ammonia was liberated 
an d , on cooling, a potassium salt crystallised. 9-bydroxy-
1-n i tro thion a oh th en was obtained as light yellovr needles 
by acidifying a.n anueous so lut ion of the potassium salt, 
and after r eery s tall t s.at Ini from ethanol (l.él g., 85/0
had :n.p. 119-121° (Pound: C, 49.2; ÎÎ, 2.J. CgTgî'O S 
requires C , 49 » -  : K , 2 . é',. ) .
5-iIydroxy-4-nitro thionaphthen was also obtained
14 5
by direct nitration of 5 " ^ ydroxythionaphthen. " To 
5-hyd roxy thiona uh then (0.114 g.» 0 . 76 mmole) dissolved., 
i.n a.c^^tic acid (5 ml.) at 10^, concentrated nitric acid 
(0.048 ml.,, 0.76 mm o le) in acetic acid (5 mi 1, , ) wa s 
gradually a.dd ed.. A red. colour was imm ed ia. t el y apparent, 
and on addition of water orange crystals were obtained. 
These formed yellow needles (O.07O g ., 475)> m .p . 119^ 
and mixed m .o . 115^  ^ from ethanol; infrared spectra of 
the t^ '^O samples in ITujol were identical.
5 -IT vd r oxy- 4 - ni. tro th i on a nh then - 2 - carboxyl ic acid.
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(LXII, R - C 0 gH ) . - xythioneLphthen-Z-carboxylic
acicl~^^ (0 . 7 5  £•» 5.8 ramol e) was dissolved in acetic
acid (20 ml.)» and concentrated nitric acid (0.24 ml., 
5 . 8  mnole) gradiiall^T added at 10^. Overnight the n i tro- 
compound crystallised. Light ye 1. low needles ( O . 5 4  g . , 
6 I/’ ) were obtained from ethanol.-, he.ving m.p. 2 7 5 ° and. 
mixed m.p. vh.th an authentic s a m p l e ^ ' 2 7 *^ ° •
5- Promo-5-hyd roxy-4 -nitro thionaoh th en (L X V ).-
1 ^ 9
To a solution of 5-brono-5-hyd roxy thionaphthen ^'
(C.I77 g ' » 0 .77 Tï>mole) in acetic, acid (20 ml.) at 10^, 
cone en tra t ed. nitric acid (O.O5 Tn. 1, , 0.77 rnmole) in 
acetic acid (2.4 ml.) was added. Addition of water 
precipitated the ni tro - comoound. v-hich crystallised as 
needles (from e thanol ) ( 0 .12 4 g., 57^ " ) with m.p. l60^ 
(pound; C. 5^ # 6 ; rl, 1.7* G BrNO  ^ 8 requires 0, 55*1;
n, 1 .5c ) ' On reduction in ethanol -v^ ith Raney-nickel 
and hydrazine hydrate, followed by oxidation with 
potassium f err i cyan id e, a green colour was obtained, 
wi th trie th2Tla,m in e and ethyl cyano acetate, indicating 
the formation of a 7~(cyano ethoxycarbonyl)-thionaphth en' 
4,5 - q u i n o n e .
T/ith excess of concentrated nitric acid, a
d i n i. t. r n - r*. o n d vp r formed . J-Eromo-5”kyd roxy thioneoh th en 
(  ^4 m g . ) p n i. s s o 1 v e d in a c e t i. c p c i d. ( ]_ ml..), end 2 
drops of concentrated nitric c c i d. were added. Orange 
needles crystal1 i s e d ; recrysta1 1 isation from ethanol 
gave a product, m.p. 211-215^ (j6 mg., (Found ;
G, 10.2 : II, 1*5« C H Erl' OpS renuires C, 50.1; H, 1 .0/ ).o 1 (C )
4 - Ur omo - 5 -h yd ro xy- 6 -n i t r- o t h "î o n a. p h then ( LXV T ) . -
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l'o 4-hromo-5-h2^drox2/thionaph th en (2.0 g., 6.7 T^mole)
\ r, cette PC id (20 m l . ) ,  c o n c en t r a. t e d n i t r i c  aci.d 
(0.55 • * 8.7 rnmol.e) rv'i s added at room t e m p e r a t u r e .
I rq T1 0 d i r tel y , 4-hr omo - 9 -h ro y v- 6 - n i tro th ion a 0 h.Ah e n
cryctallised; it formea orange needles, m.p. 1 7 5 ~ ^ 7 ^ °
(1.4 g , , 5 8/- ) f rom e th a no 1 ( Found : C , 15 • 5 -• H , 2.0: F , 5 • ^  •
O^FfRrUQ^q reçu ires C, 55.1 ; ", 1.5; F, 5.If).
T h e  m 0 th y 1 e t ri e r . p r e p a r e d  h y  r e a c t i o n  r^ith a n  
•^a-crss o f  e th er ea 1 - e tha n o  1 i c d i a z o m  e t h  a.n e , f o r m e d  na 1 e 
ge l l o v r  -000 g lee. ( 557 ) j Tr, p , 11.4 .5'^ , f r o m  e t h a n o l  ( F o u n d :
C, 57.6; n, 1 .9 . C„H/BrrO S require? C, 57.6 ; H, ?.U) .a a
5 - Be n 7 o g 1 o X 2't hi.on a. n >i t h e n ( LXV III) . - Fi th benzoyl 
chloride (j.Ol ^., 0.022 mole) in ice-cold pyridine for 
50 min., 5 - h y d r o x]; th Iona oh th en (5.55 f * » 0.022 mole) gave
o 6
th € h en zo yl d er iva tlv e , forming cubic cr 3a s tais (4.97 
887), m.p, 111 .5-1].5°' from light petroleum (b,p. éO-80^) 
(Found; G, 7 * G ; H, 4.1. requires C, 70.9 î
H , 4.0^::).
5- Ben zoyloxy-l-bromo thionach th e n 5 -Benzoyloxy- 
th ionaph th en (0.529 g ., 2.0 mmole), sodium acetate 
( 0 . 55 g " » 5*0 rnmole), a.nd bromine (O.JJJ £*» B . 0 mmole) 
were heated in acetic acid (10 ml.) on the steam bath 
for 50 min. Addition of w^ater precipitated the crude 
bromo - com-pound , m.p. 1 5 0 .5 ° ( 0 . 65 g . , from light
■oetroleum (b.u. 60-80^) (Found; 0, 5^*0; !1, 2.7* C^^H^BrO^S
renuires C , ,1 ; H , 2 .7 7) *
h^ /d roly sis in 57 sodium h^/droxide solution at 
50  ^ gave 5-Bromo-5-h3'd rox]/1hionaphthen in quantitat ive 
3^ 1 eld,, m.u. 155° f^^ d mixed m . o . 155”  ^56°.
5- Ben zo 3^ 1 oxy- 5-n i tro thionanh th en (LXIX).- To 
5 -bcnzoiBop'th ionaph then (0.80 g., 5*^-5 r^ f^ -ole) in acetic
acid (10 ml.) containing concentrated sulphuric acid (1 ml.), 
fuming nitric acid (0.22 m], . , 5*5 mmole) was added.
Fi th in 2 hr., 3^ ellov^ needles of 5-benzo vloxy- 5-ni tro- 
thionanhthen appeared. A.fter crystallisation from eth]Tl
acetate, this had m.p, 180^ ( 0 . 65 g . , 6^ 7" ) (Found; C, 60 . 5 ; 
ÏI, 5 .0 . H^NO^S requires C, è o . 2 ; H, J . 07') .
5 -Pydrox y- l-n i tro thion anh th en . (I.XX).- Pr el iminary 
a. t tempts to h 370 roly se the benzoyl compound v/ith dilute 
sodium h 3/ d r o X i d e solution wer e unsuccessful. 5-Een zo36loxy- 
5-nitrothionaphthen (O.yO g., 2.5 mmole) was refluxed
5n absolute ethanol (200 ml.) containing concentrated 
hydrochloric acid (5 ml.) for 12 hours. The ethanol 
was removed under reduced pressure and the product 
extracted, with 21:-sodium h3Tdroxide solution. On 
aoidifteation of this solution, the hydroxy-comnound 
rra. a precipitated. Pine yellow needles (O.OéO g.), m.p. 
164.5-166 ,^ were obtained from water ( Found.; C, 45.2;
II, 2.6. CgH^iTO^S requires C, 49.2; H, 2.67). Starting 
material (O.47 g .) was recovered.
4 - Promo - 9-h yd roxi^- 5-n i tro th ion anh th en ( LXVII).- 
To 5 - h y d r o x 3/- 5-nitro thionaoh then ( 0 . 04 5 g . , 0.22 mmole) 
and sodium acetate (0.05 g ») in acetic acid (4 ml,), 
bromine (0.0 5 5 5 g * , 0.22 mmole) in acetic acid was added.
tat e
of 4 - bromo- 5 -hyd rox]^- 5-nitro th ionaoh th en separated;
fine needles (0.051 g . , 84.5/7), m.p, 125“ b51^,
were formed from light petro], eum ( h . o . 6 0-80^) (Found:
C, 14.8; H, 1.8. C^^H^BrTTC S requires C, 55 .1; E, 1.57) .
4 ,6-Dihromo-4,5-dihydro-4-nitro-5-oxoth ionanh th en 
(LXXIV).- o 4 , 6-dihrorno-5-hydroxythionaphthen (0,81 g . , 
2,6 mmole) in acetic a c i d  (5 ml,), concentrated nitric 
acid (0,40 ml.) was add ed at 10^. Orange crystals of the 
wRto-compound formed, dilution of an acetic acid solution 
of the k e to - compound with ter gave 6 -bromo-d-h^rd roxj^-
4-ni tro th iona oht>^ e n , m.p. 124'' and mixed m.p. 127 . A
positive Craven ’ s test v/i th ethyl c i^ a.no ac e t a, t e and 
tri eth^Tl amine wa s obtained after boiling in benzene.
5 - Amino -4 , 6 - d ibromo th ionaoh th en- 2- ca rb ox]/] j ç 
.acid (LXXX),- Bromine (6.64 g . , 0.0415 mole) was added 
to 5-am ino thionaph th en - 2 - car boxy], ic acid (4,0 g . , 0,0207 
mole) and sodium acetate ( 5,1 g .) in hot acetic acid 
(800 ml,), and the resulting solution heated at 80^ for 
10 min. On cooling, prisms of the d.i bromo-corn no un d 
crystallised; pale 3/ elloy; needles (4.7 g . , 657 ) from 
etha.nol had m , . 514^ (Found: C, 50.6; li , 1. . 7 • C^ IIp. Fr^NO^S
r en I’ires 0 ,  50.8; K, 1.47).
5- A m i n o - 4,6-d i bromo thtonanhthen (L X X Y 1 1 1 )
Th e barium salt ( 0 .15 8 g . ) of 5-aiiiirio-4 , 6-d ibromo- 
th ion aph th en-2-car boxy], ic acid, wa s prepared and heated. 
in va QUO with barium hydroxide g») • At
d eca.rboxylation took place, and 5-A.Tnino-4,6-d ibro mo­
th ionanhthen sublimed onto a cold finger. Colourless 
cr^/stals (0.0 58 g . , 557 ) from ethanol had. m.p. 119^
(Found: C, 51.4; 11, 1 .5 * C j_ Br S requires C, 51.5;
1 .87).
5 - A m i n o - 4 ,6-fibromothi onaphthen was also o b ta in ed 
from 5-am in 0 - 4 - bromo thi ona.phthen . To a solution of this 
compound. ( 0.5 0 g . , 2.2 mmole) in acetic acid ( 5  ml.) was
pdded broraine (0.59 g., 2.2 mmole) in acetic acid at 
room t emperatu.r e , and the crude product wa. s precipitated 
VÛ th wa t e r . .After recrystallisation from ethanol it had 
m.p. 1 1 5 ^ and mixed m.p. 1 1 8 (  0.5 2 g . , 1 1 % )  y infrared 
spectra of the two samples in Nujol w^ere identical.
5 - Am in o - 6 - br o mo - 4 -n i t r o th i o n a uh th en ( LXXX11 ) . - 
Bromine (0.l6j g ., 1.0 mmole) in acetic acid ( 5  ml.)
;a s gradue.lly added, to a solution of 5 -amino-4- n i tro­
th ionaph th en (0 . 1 7 5  g "» 0 . 9 0  mmole) and sodium acetate 
(0.2 g .) in acetic acid (10 ml.), and the resulting
V
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solution heated on the steam bath for JO min. The 
bromo-comnoun d was isolated by the addition of water, 
and crystallised from ethanol as orange needles ( O . I 7 6  g ., 
7I/) with m.p. 144-149^ (Pound: G, JJ.l; H, 1.7*
CgH BrNgO^S requires C, JJ.2; H, 1.87).
5-Brom.o-5-nitro th i onanhthen . - J-Nitro thionaph th en
(5.0 g., 0.0279 niole), bromine (4.47 0.0279 :nol e ) ,
and sodium acetate (2.J g .) were heated under reflux 
for 1 hr. in acetic acid (200 ml.) and, on cooling, 
red. needles of the crude bromo-compound separated.
1 ur1fication in hot ethanol (charcoal) gave pale yellow 
needles (5.9 2-, 82%), ra.p. 171°( Lit. lyO-iyi”).
9-Amino-5-bromothionanhthen (LXXXIV).- J-Bromo- 
9-nitrothionaphthen (4.^9 S*» 0,0178 mole) was hydrogenated 
vrith shaking in ethanol ( 2 90 ml.) at room t em.peratur e. 
Platinum oxide ( 200 mg.) was used as ca tal^ Tg t. After 2p- hr,, 
1200 ml. of hydrogen (0.09 mole, 9^ /') had been taken up.
The solution was reduced to 90 ml. and dilute hydrochloric 
acid added. The amine h yd rochloride thus precipitated, 
was extracted y-ith hot benzene to remove any unchanged 
nitro-compound and recrystallised from water as colourless
MM
needles (2.64 g., 6O7 ), m.p. 262° (Pound: C, j6 .2 ;
E, 2.4. C^EyBrClES requires C, j6 .J; H, 2.77).
The free amine had m.p. 80-62^. Fi th acetyl 
chloride in pyridine at J ^ (2 hr.), it gave the ac ety]
Od er iva t iv e ( LXXXV ) , forming pi a. tes ( 807 ) with m.p. lé4 
from benzene (Found: G, 44.8; H, J. 2. C^^PI^BrNOS requires 
G , 4 4.4; H , J . 07: ) .
9-Acetamido-5-bromo-4-nitrothiona oh th en . - To 
5-a.c et a^ mid o-5-bromo thions ph th en (1.90 g., 7 *8)4 mmole) 
in acetic acid (4 ml,), concentrated nitric acid 
(0.46 ml., 1*2 mmole) was atdded., and the solution heated 
on the steam bath for IJ min. On cooling, cr^ r s tal s of 
9 -_a c eta mi do - J-bromo-4-nitro th ionanh th en separated; pale 
3 ' e 1.1 o y.- needles (1..29 g , , 5 ) from ethanol had m.p. 197°
(Found: IT, 9.2. G^  ^ HyBrF ^ 0^8 requires E, 3.97).
The addition of excess nitric acid (0.9 ml.) to 
a solution of J-a c etamido-J-bromo thionaphth en (O.JO g .) 
in acetic acid (1 ml.) gave, on hea.ting on the steam 
bath for IJ min., y ellow crystals (0.40 g.) of 
undertermined structure.
9-Amino-5-bromo-4-nitrothionanh th en (LXXXIII) .-
E yd roi y s i s of 9 - ac e tarai do - J-broTno-4-nitroth ioneph then 
(1.29 g., 5 . 9 7  mnole) in ethanol a.nd 2N sodium hydroxide
solution (lîl) on tlie steam bath gave, on extraction 
with ether, 9-amino-5-brono-4-nitrothion aoh th en, wh i ch 
formed ora.nge prisms (0.87 g . , BOf ) . m.p. IJO^, from 
ethanol (Found: N, 10.2. Cgh^BrN^O^S requires IT, 10. J/').
h'h en J-am i n o - 5-bromo-4-ni tro thionaphthen (O.SO g . )
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was heated under reflux with O l a i s e n ’s alkali  ^ ( 2J ml.)
for J hr., ammonia was liber a. ted. IJnreacted amine was 
recovered (0.29 g . ) b^  ^ dilution of the reaction mixture 
with water, and isolated b^ - ether extraction. Acidification 
of the ba.sic so lut ion remaining gave pale ^Tellow 
needles (O.Jl g . ) of J-bromo-B-h^wl roxy-4-ni tro thionaph th en 
(from benzene), m.p. 1 5 9 ° f ^ d mixed m.p. 1 5 9 °* Th e 
infrared spectrum in nujol was identical with that of 
au th en tic 5-bromo-J-h];d rox 3/-4-nitro thionaph then .
9 - Am ino- 5 , 4-d i bromo th iona/oh th en ( LXXXV III)
Bromine (0.152 g ., 0.95 mmole) in acetic acid (1.2 ml.) 
was added graduall}^ to a solution of 5 “ f-mino-J-bromo- 
thionaphthen (0.21o g ., 0*95 mmole) in acetic acid (10 ml.) 
After 5 min. heating on the steam bath, 5 “®m i n o - J ,4- 
d ibromo thionaph th en hj/d ro brom ide was precipitated. It
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was shaken with ether and sodium hydroxide solution, and. 
th e d ihromo-prn in e obtained from the ethereal so ] u tion 
bv removal of the solvent under red.uced pressure, bbite 
needles (0.21 g ., 7 2 /) were formed from light petroleum
(b.p. 6 0 -C 0 ° ) and had m.p. 14 (Found: C, J1.7 ; H , 1.6.
0 plip. Fr^NS r equir es C , J 1 . J ; R , 1. 67 ) .
9-Ac etamido-5,4-d ibromo thionaphth en (LXXXVII) .- 
9-Acetamidothionaphthen (0.82 g., 4.J mmole), bromine 
M. .j6 g . , 8.6 mmole), and sodium acetate (0.8 g.) vrere 
b rated under reflux in acetic acild (40 ml.) for 1 hr. 
.Addition of wa ter precipitated a d ibrom o-com-no und which 
formed needles (0.87 58/)» m .p . 1 7 2 ^, from benzene
(Pound: C, J4.5 ; H, 2.0. 0^ Br^ROS requires C, J4.4;
R , 2.0 7  ) .
Hydrolysis of this compound (0.109 g.) in ethanol 
and 2H-sodium hydroxide solution (1 :1) on the steam bath 
gave 9-amino-5 , 4-d ibromo thionaph then (0.081 g . , 90/-), 
m . u . 14 end mixed m.p. 14 J ° . The inf ra.r ed spectrum 
in nujol was identical with that of authentic J-amino- 
J ,4-dibromothionaphth e n .
9 -II e thox.yth ionanh th en . - Dim e th^ '-l sulphate
(0.189 g., 1.5 nmole) was added to 9-h^ d^ roxy th ionaph th en 
(0.23.7 g . , 1 .5 nrnole) dissolved in 0. IN-sod ium hj^droxide 
(14.5 ml,), and the resulting mixture shaken for 1 hr.
The methoxy compound ve s iso].ated .9 s an oil hy extraction 
th ether. "'■Thite needles (0.12 g. , 5^/’) ? m.p. 42^
( 1 it. , 44*^ ), were obtained b]^  sublimation at 190°
under reduced, pressure.
4 - Bromo - 9 -m e thox]/ th ionanh t hen ( LXXX IX).- 
5 -I'ethoxy th ionaphth en (0.079 g . , 0.43 mmole), bromine 
(0 . 0 7 7  g. * » 0 . 4 3  mmol e ) , r.nd sodium acetate (0.08 g . ) 
were warm ed in acetic acid (4 ml.) on the steam bath 
for 5 0  min. The bromo-comoound wa s precipitated h y the 
addition of water; cr^ustallisation from light petroleum 
(b.o. 6 0 - 80° ) gave needles (0.09J g . , 8 O7 ) with m.p. 9^°
(Bound: 0, 44.2; H, 2.6. C,,H^BrOS requires G, 44,5; 4Î, J.07)
4-Bromo-9-m etho X 3/thionaph th en was also prepared 
from 4-bromo-9-hydroxythionaphth en by méthylation with 
dimeth^/l sulphate, then having m.p. 8 8 - 8 9 ^ and mixed 
m.p. 89°.
5 .4-pi b r o m o - 9-m ethoxvth ionaoh th en (X C ) .- (a)
4-Br orno-9-m e thox^^’th ionaph th en ( 0.028 g., O.II 5 mmole)
wa s heated in acetic acid wi th bromine (O.OI9 g ., 0.118 
mmol e) on the steam bath for JO min., and. J, 4- d ibromo- 
9-m ethoxythiona oh th en wa s precipitated by water. X h i t e 
crystals (0 .O27 £!•# 7 Jn ) v-ere obtained from light 
petroleum (b.p. 40-é0°), m.p. 119° (Pound; 0, J J .9 ;
R, 2.1. CgH^BrgOO requires C, JJ.6 ; H, I.9 7) .
( b) J , 4-Dibromo-5~h3^d roxy thionaph th en^ ( 0 . J7 g . , 
1.2 mmole) was shaken with 0 .IN- so d ium hyd ro xide (12 ml.) 
and dimeth^/l sulphate ( 0.16 4 g . , l.J mmole) for 1 hr.
The m e thox37-compound , obtained b^  ^ extraction with ether, 
had m.p. and mixed m.p. 122° (O.IJ g ., 7^7) (from light 
petroleum (b.p.40-6o°)). starting material (0.18 g .) 
war recovered.
9-].Iethox3/-4-nitro thionanh then . - J-Hyd roxy-4- 
nitrothionaphthen wi th an excess of d iazom ethane in ether 
gave 9-methoxy-4-nitro thionaphth en as pale yellow needles 
(R27) (from ethano1) , m.p. 108° (Found; C, J1.6; H, J .J .
' NO S requires C, J1 .9 ; N » 2 .97 ) .
I y
Trin i trothionaohthens .- A11 empts to nitrate 
9 - ni tro thionaphth en-2-car boxyl ic acid, at room temperature 
led to recovery of unchanged startinv material.
y y
Concentrated nitric acid (1.2 rnl , , 0.019 mole) and 
concentra.ted sulphuric acid (9.0 ml.) were added to a 
solution of 5-ni tro th ionaphthen-2-carboxylic acid 
(2.1 p., 9.4 mmole) in acetic acid ( JO ml.), and. the 
solution was heated on the steam bath for 20 minutes.
The addition of water precipitated an orange solid 
par tial.l^ T soluble in a small amount of benzene and 
f o r m in g 1 i gh t br o wn c r y s t a.l s ( 1 . 0 g . , 297 ) wi th m.p. 16 J ° .
The residue formed pale 3/elloyr needles (0.4 g., 1?7), 
m.p. 15J°, from ethanol. The infrared spectrum (Nujol) 
of neither compound showed carhox^O. absorption; analyses 
irr ere consistant with t r i n i t r o th i o n a oh th en s (Found; (a)
G, 59.7; H, l.J; N, 1^.4 ( b) C, JJ .2; H, 1.0. C^H_N,0gS 
requires C, JJ.7 ; H, 1.1; N, IJ.67) *
II e t h y 1 9-h,yd roxy th ion auh t h en - 2 - c a r b o x 3^ 1 a t e . - 
(s.) Excess of d ia zom e than e (0.1. mole) in ether wa s added 
to a solution of 9-h3;"drox3/thionaphth en-2-carbox3rlic a cid 
( 5.91 g . , 0.016 mole) in ethanol. .After 24 hr., the 
solvent was rem.oved under reduced pressure. The ester 
formed plates (J.6 0 g ., 9 67) from benzene wi th m.p.
162-16 5° (Found: G , J7'9 ; h , J.9 . G^  ^ HgO ^ 3 requires
c, 57.7; 5.97).
(b) A point ion of J-hyr^  roxyth ionaph th en-2- 
carboxylic acid (14,2 r; •, 0,075 rnole) in methanol (250 ml,) 
containing concentraited hydrochloric acid. (10 ml.) waa 
heated under reflux for 4 hr. The solvent r;a s removed 
under reduced pressure. The white residue obtained in 
this nay nas dissolved in ether, a.nd extracted nith 
sod_ium carbonate solution to remove unreacted hydroxy- 
acid. The ester (12.0 g ., 7?%) nas Ghta^ined by distillation 
of the ether, and ha.d m . p . 1^5^\ and. mixed m.p. 165°
V'i th sam.ple prepared by method (a), p*"— iona ph th en-
2-car boxy lie acid (2.4 g.) na^ s recovered.
"Ti th acety]. chloride in pyridine at  ^° ( 2 hr.), 
the ester gave the ac etyl derivat iv e nhich formed 
feathery needles (8570 ni th m.p. 150  ^ from ethanol 
(Pound: 0, H , 4.0. G^^R^qO^S renuires G, 5 7 « ^ ;
R , 4.07) .
5-Bromo-5-ni trothionauhthen-2-ca rboxylio acid 
(.XGTY).- b'h en bromine (R.O g ., 0.0^0 mol e) na s gradually 
added to a solution of sodium 5 4 trothionaphthen-2- 
ca rboxyla t e (12.0 g ., 0.04^ mole) in na ter (1 1.), 
a bromo-compound nes precipitated (11.0 g ., 75^0»
Efficient stirring na s reouired to prevent the product
from being contaminated by unbrominated acid. Crystallisation 
from ethanol gave material of m.p, (lit.^
510 )^ (9*^ g ., 657). ( t'h en 5-nitro thionaphthen-2- 
ca rboxyl ic acid. na. s heated under reflux ni th bromine 
and. sodium, acetate in ac et i. c acid, it na s all recovered- 
unchanged.) .
Barium. 5-bromo-5-ni tro thionaph then-2-carboxyl ate 
na. s precipitated from a. solution of the sodium salt by 
addition of a eu ecus barium chloride solution. After 
thorough drying, the bf-rium s?lt (O.^O g . ) nas heated.
T”itVi barium hy d roxi de (O.hO g.) at O .5 mm. .At 5^^^ 
vigorous decarboxylation took place and the product 
obtained by ether extraction crystallised from ethanol 
s pale 2;^ el loir needles (0.12 g. , J27), m.p. 175  ^ and
mixed m.p. ni th 5-bromo-5-ni tro thionaoh then iy2°; 
infra.red spectra in. Nujol of the tno samples were identical 
(Found; C, 57. 5; .H, 1.5. Gale, for G^H^BrRO S: G , 57.2;
R, 1 .^7:).
ITethyl-5-acetamido thionaohth en-2-carboxylat e.- 
"^o 5 -^-^4no thionaph th en-2- carboxyl ic acid (l.l g . , 5*7 
mmole) in m etha nol (20 ml.), an excess of ethereal 
diazomethane (0.01 mole) nas added. The solvent na s
al.lonecl to évaporante overnight, and the product 
dissolved in p^ '-rid.ine (10 ml.). Acetyl chloride (0.4é g,,
7 . c rri'ole) na s ad^ed at 5^, and the a c et yl com'oound 
■nreci pita ted h y addition of nater. '".'hite cr^^stals 
(0.77 8 " » 5 47) o b t a i n e d  from b e n z e n e - l i g h t  petr o l e u m
(b.p, éo-80'^) had, m.p. 151^ (Found: G, ^7*8; H, 4. 5.
C R no S requiiec G, 77 ; H, 4.57).
1 1 J. 2
H ethyl 5-bromo-5-ni tro thionauh then-2 - carbox^^ls te . - 
2“ rromo-5-nitro thionaphthen-2-ca rboxylio acid. ( 1 .9 g . , 
0,^ mmole) in methanol (100 ml.) r>ith ethereal d ie.zom e than e 
(0.01 mole) (12 hr. ) gave th e e s ter ( 1 .8 p . , 9 4/ ) , 
211-212° (from ethanol) (Found: G,  J B . J ;  H ,  2.0. 
renuires C, J8.0; H, 1.$/).
deduction wjtb Ran ey Rich el and Ri/drazine Hydrate. - 
Til e preceding ester (1.2 g . , mmole) vas h eat ed in
ethanol wi th Han ey-nick el (2 g.) and h^'drazine h^'drate 
(7 ml.) on the steam bath for JO min. The product 
obtained "05^ the removal of solvent under reduced pressure 
va s immediately dissolved in pyridine (IJ ml.), and 
acetyl chi oride (0 . JO g., J.8 mmole) was added dropwise
at 5°. Addition of mater precipitated meth^^l J-acetamido-
7 !
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thionaphth en-2-ce rboyyle.t e (O.éj p., ^97 )m . p. 151 
a Tld mixed m.p. IJO-IJ1° ( from benzene-light petroleum) .
? , 5-Dibromo- 5 -ni tro th lona.oh th en ( XGY ) . - G odium 
J-bromo-d-ni tro ttiiona,phthen-?-carboxyla.t e (2.4 p.,
7.4 mmole) vas treated in distilled vater (JO ml.) 
ni til excess of silver nitrate solution. The precipitated- 
silver salt vas dried and suspended in dry carbon tetra­
chloride (40 ml.) containing bromine (1.18 g., 7*5 mmole), 
and the mixture vas heated under reflux for 2 hr. The 
precipitated silver bromide v^a s removed from the hot 
solution. 2 , J-ribromo - 5-ni tro th iona.ph th en ( 1 . 7 J g * ,
70/ ) cr^'^stalli sed i n yellov needles vi th m.p. 21
( lit. 7  217-218°) .
5-Iodothionauhthen .- J-Aminothionaph then 
sulphate (ll.J g ., 0 .0J7 mole) va s suspended in vat er 
(1 1.) containing concentrated sulphuric acid (IJ-J ml.). 
Sodium nitrite (4.J p., 0.0J7 mole) in vat er (JO ml.) 
vss added dropvise at J° and the mixture stirred for 
2 hr. The cold solution vas filtered directly into one
of potassium iodide (8 J p., O.J mole) in va ter (JOO ml.)
and heated for 20 min, at 90°. Extraction vi th ether
u o
f old. o vec by va shin g of this ex tr ac t vi th p o t a s s i i m  i o d i d e  
soliii-.ion and so d inn h y d r o x i d e  s o l u t i o n  y i e l d e d ,  on 
r e m o v a l  of ether, 8 - i o d o t i on a tb en . C o l o u r l e s s  c r y s t a l s  
( a , 1 y . . 497 ) frorn e t h a n o l  ha d n . p, 54 ^  ( P o u n d  : C , J7 .1 ;
H , 1 . ^  . 0 ,,1^ IS r enu ires C , J o . 9 ; rJ, 1 . J J ) .
5,01 _T)i th Ï or a oh th er ■'O a r e- 2 , ? ’ - d i o a rbo v"'"l i c
a o i d (XCYI).- The y e l l o v  a’aterial obtained as by-product
r the Tu ch er er r ea c on^' vas t a k e n  up in a, rrilninun
aaionnt of dry pyr id in e , and the solution f i l t e r e d
ft rough >,erdrred filter paper , The solution vas then
d i 1 u t ed. i. th wa ter and a c e t i c  acid to g i v e  th e a c id
v-ith n.p.J^jé'O^, peaks at l6yO and 1284 cm. ^ v^ith
-1
> ' r o a d a b s o r r> t ion 1' e 1 o t -• 2800 c m . i. n t ne i n f r a r e d  
s n ^  e t r m  i n F u j o 1 sh o vre- d th e o r e s  en ce of c a r b o y  yl i c acid 
f u n c t i o n c. v h i l s t  the peak at JJ^O cm. ^ i n d i c a t e d  the 
s e c o n car]' a m i n e  ( P o u n d î C , 58.5; il, J . 0 : IT , J , 8 ; S , 17.4  
0 !! iTO^Pp rpniii-rep 0, 88 V  : II, 8 .8 : ' ■ , J i . 8 ; 8 , 1 7 .O7 ).
5,5'-Pith ion a oh th en y1a m ine T h e  foregoing acid 
(4,7 g . ) , co'pper bronze (8.0 g . ) , and. nuinoline ( éo rnl.) 
vere heated under nitrogen at 180° for 45 rnin. Vigorous 
evolution of carbon dioxide va s observed,. The mixture
vas alioved to cool under nitrogen and diluted with 
ether. After removal of the copper bronze and ether, 
the quinoline solution wa s poured into - sulphur ic 
acid ( éOO ml.). A brown solid was precipitated; from 
ethanol it formed feathery needles ( 2 . 2  g ., ) » m.p.
1 J 7 - 1 J 8 ^ and mixed m.p. with an authentic sample ljé° 
(infrared spectra, of the two samples in nujol were 
i d e?i ti ca 1 ) (Found: C, 6 7 .9 ; IT, J . 8 ; F , 5.2; G, 22.7*
recuir es C, 6 8 . J ; H, J.J ; F, J.O; 3, 22. 8 7').
5-J ’-Fi th ion a ph th enylami n e was pr epa red 
r n a T'ibi guo VI sly by 2 n a.da.ption of the method used for 
or epa ring d.iph enylamine^^ ^  . J-Amino thionaph then ( 0 . JO g . ) 
and J-a.mino thionaph th en hyd r o chi or i d e ( 0 . J J g.) were
heated, together in a sealed tube at 240° for JO hr.
The secondary amine was extracted with hot ethanol 
a n d formed needles (0.25 g . , 4 JJ, ) from e th an o 1 wi th
m .u . 15^°.
1 - Am i n o m A t h y 1 1 h .i on a. nh th en h y dro chlor i d e ( G ) . -
5-Chloromethylthionaohthen^éo (4.J J g ., 0.02J mole)
was dissolved, in d imethylformamid.e ( 7 0  ml.) and heated, 
under reflux w-ith po t a s s ium phthalimid. e (4.59 g . , 0.025 
mole) for J hr. mg e condensation product wc s pr ec imita t ed
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h y the a-dditton. of v^ va.ter, and formed white crj^sta.ls 
( J , JO r., 7 J/ ) with m.p. l 6 p ^  (lit.,^'^" lë J° ) from 
ethyl acetate.
A slight excess of hydrazine hydrate (J ml. J 8 - 
100/. ) was added to the substituted phtha.lirnide (J.O g.) 
in ethanol (250 ml.), and. the solution heated under 
reflux for 2 0  min. \ wh. i t e solid c r s t a 1 1  i s e d from the 
hot. solution, and after further ref lux in g in the presence 
of dilute h^vdro eh lor ic a.cid (50 ml.) for JO min., the 
so 111 t ion obtained by filtration was m.ade ba.sic with 
dilute sod ium hydroxide solution and extracted, with 
e th er to gi.ve 1 - a.m i n o m th y l thiona oh th en ( 2.47 g»> 89/' )
a. s a pale yello^z l.icuid. The am i n e wa s char a.c t er i s ed.
,a s the hyd ro chi or id e which formed colourless cubic 
crystals vm. th m.p. 259-2^0° from ethanol ( Found ; C, 54.1;
R. , 5.2. C ^  q GIITS r epuir es G , J 4 .1 ; K , J . 1/' ) .
J-( Dime thylamin cm ethyl ) - th iona.nh th en hyd ro chlor id e 
( G T ) . - J - Am i. n o m e th y 1 1 h. i o n a p h t h en (l.O r.), jél formaldehyde 
solution (4 ml.), formic acid (4 ml.), and water ( 8  ml.)
Vere gently warmed under reflux on the stea.m bath for 
4 hr. Excess dilute hydrochloric acid was added and the 
solvent removed by distillation under reduced uressure
1 0 1
leaving 1- ( d ira e th yla m inom ethyl ) - thionaph th en hyd ro chlor id e 
a.s a vhite solid; colourless prisms (0.99 g., y 1/, ) 
fro '11 ethanol had m.p. 216-222*^ (Found: 0 ,  J 7. J ; H, é.O. 
requires C, JS.O; H, é.27).
l-(?'orpho lino met hy 1 ) - th ion a oh th en hydrochloride 
( CII ) . - So dam id e ( J . 7 g » , 0 . 0 9 J mole) was added to 
ohlororn ethyl thionaph th en (6.0 g,, O.OJJ mole) a.nd 
norpholine (2.86 g ., O.OJJ mole) in dry toluene ( 7^ ml.), 
p d the mixture heated vigorously under reflux for 24 
hr. A considerable d a rk en in g in colour was observed, 
hater was added to decompose the excess sodamid e , and 
the organic layer separated. Distillation of the toluene 
under reduced, pressure afforded, the amine as a. faintly 
coloured linuld, b.p. 208-210°/18 mm. 1- ( T'Oruh ol inomethyl ) 
th ion a. th en h y d ro chlor id e obtained wh en dry hydrogen
chloride was passed into an ethereal solution of the 
amine, and formed rhite needles (4.66 g . , J2/J) with 
m.p. 22J° from chloroform (Found: G, J 7 * 8 ; K, J.8. 
G^^H^gClNOG renuires C, J7-yî 91, 6 .0 7')*
A series of amines (table 4) were prepared and 
characterised by this procedure.
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Table 4
h m id lJ l b . T). ( 18 mm . )
5- ( o y r r o  1 i d in o m e th yl ) - 1 h 1 o n a.ph then 14 2 -14 6 °
5-(piper id in om ethyl)-thionaphth en^ 15 2-1jé °
J“( 2 ’ -methylpiper ir] inorn ethyl ) - thionaph th en l4é-lJ0°
J-( cycloh exylarriinora eth yl ) - thionaph then 195-205°
Analys es
m.T).(liCl) Yiel d Found Reouired
1'70-191° 6O/ C, él.O; H . é . 4 C, él.,8 ; îi. ^ . 47:
l.Q4-TQ5° ,597 C , 8 0 . é ; ÎI, 5.8 C, 80.7; H,
21 2" 5 5a 0 , 6).4; H, 7.0 C, 65.9 ; E, 7.27
19 8° C , é 4 . 9 ; H, 7.0 c ,  6 5 . 9 ; H, 7.27
ch3 re c t er i sed e s the amin e Perchlor“e t e
Acid cbl.oride of 5-n i tro thionanhth en-2- 
carboxyl i o acid . - -F i tr o th iona nh th en-2-carboxyl ic acid 
( 5 .0 g.) wa. s dissolved in thionyl chloride ( éo ml.) 
and heated under refl.u.x for 2 hr. The acid chloride, 
obtained as a brown crystalline solid by distillation 
of the excess thionyl chloride, formed pale yellow 
needles ( J . 1 p., 957) with m.p. l6o° frorn ethyl acetate 
(Found; G, 4J .0 ; rl, 1 .7 . C^F^CIHO^S requires G , 44.7;
E, 1 .77:) .
t V.;
2 - ( r'oruhol ino ce r bonyl ) - 5-n 1 tro th innanhth en ( CXI I) , - 
To the crude acid chloride obtained from 5 9 1ro- 
thionaphth en-2-c?.rboxy].ic a.cicl ( 5 « 0 g . , 0.022 mole) 
dissolved In 'analar * benzene (120 ml.), morpholine 
(j.2 ml., 0.04 4 mole) was added gradually with shaking 
at 10°, and the mixture heated und er reflux for 1 hr.
On cooling, the morrhol in e hydrochloride was fi.ltered 
off. Ilorpho’i i no cr rbonyl. ) -5- ni tro th ion anh then , obtained
on removal of the benzene by d i st il la. t ion , formed pale 
yellow plates ( 4.55 g » , 75a) v^ i th m.p. 189-190° from 
ethanol (pound; 0, gj.c: H, 4.4. renuires
G , 5 J . 4 ; II, 4 .15 ) ,
A (j0/• yield was obtained wh en the r eac tion was 
carried out in ice-cold pyridine.
Other substituted amides r^repared from the acid 
chloride of p-nitrothionaphthen-2-carboxylic acid by 
the same urocedure are listed in table J.
T able 5
Amide m.p.
2 - ( d irn eth y lam in o car bony 1 ) -5 -ni tro th ion. aph then 141-142
2 - ( pyrrol i di.nocarbonyl)-5~nitro thionaph th en 19 4-195
2-(pip er id ino carbonyl)-5-n i trothionanh th en 1 J 2^
o
o
104
A n a l y s es 
F o u n d  P e n u i r e d
c , 5^.7 ; TrT , 5.8 c . ,82.8; H, 4 . 0/
c. 56 . 5 ; M, 4 . 9 c. 8 6 .9 ; H, 4 .47:
c. 5 7 .9 ; P , 5.0 G, 5 7 .8 ; 'Î. 4. 97
G-Amtno- 2 - (morpholinomethyl}-thiona p h t h en (C X I V ) .- 
'To 2 -( morpholinocarbonyl)-5-nitro thionaph then (4,50 r.) 
suspended in ethanol (150 ml.), 98)' hydro zine hydrate
solution ( 5  ml.) and Haney-nickel ( 2  g.) were o.dded, 
e-'id the mixture >). eatel gently on the steou-i bath for 1 hr. 
The hot solution was filtered to remove the F.an ey-nichel, 
a d on cooling, 5 -am ino- 2 -( m o r pho 1 ino carbonyl ) - th ionanh th en 
(OXIIl) ( J . 6 J g . , 90/.) cry stalli sed ; fine needles- from 
m e thanol had m.p. 189°.
The amine (1.00 g.) together with lithium, 
aluminiu m hydride ( J . 0 g . ) wa, s dissolved in tetra h y d r o ­
fur an (90 ml.), and heated under reflux for 48 hr; water 
ira s added gradually to decompose th e excess lithium 
aluminium hydride, and the solution made ba.sic with 
anueous sodium hydroxide. The tetrahydrofuran was removed 
b y distillation, a, n d 5 - a.m i n o - 2 -( mornh oil nom e thyl)- 
th i n n a nh then isola, ted by ether extraction. Yellow 
crystalline pl.ates (0.59 g . , 6 5 7 . ) from ethyl acetate
ht.fl 147° (rouPflî C, a? .8; E,  ^ G IT î^’ ,CG
1res C, 62.9; lî, 6 . h/ ) .
The other ni. tro - am ides were converted into 
d i arn i n e s ( T a. i T. c 6 ) by the s am e procedure. Th e s e a.rn in e s 
could not be obtained crystalline., and are characterised 
ch em i. c a 1 ] y a s the F -ben zoj/l d eriva tives .
Table 6
: T a TG1 n e la . p . ( a.m in o - a m i d
148 op - a i n o  - 2 - ( d i n e  t h y l a m  in on e t h y l  ) - th  iona.ph th en 
5 - a m i n o - 2 - (  p y r r o l  i d. in o n  e th  y 1. ) - 1 h  i o n a p h  th en 1 b 2 - 1 J 4
5 - a m  i n o  - 2 - ( p i p e r i  d i.nom e t h y l  ) - th iona.ph t h  en
o
l6 :^°
. ri. ( p-ben zoyl derv.) Found
Ana.ly s e s
Hen u i. r e d
2 1 0 - 21.1
207.5°
200°
G, p .  6; E, 9 . 9  G, fp.é; H, 9 .9 /
C, 7 1 .1; H, 6 . 5  0, 71.4; H, 6.0/
C, 7 1 .8 ; H, 8 . 9  C, 7 2 .0 ; H, é . p
8 -Benzylox;^t.8 i onaphthen-?-c.orhoyylic aci 8 ( G V ) .-
(a) To methyl 5 “Eye rox.3/th ionaph th en-2-ca rboxylat e 
(4.40 p., 0 . 0 2  2 raole) dissolved in ethanol ( 2 5  ml.), 
sodium hydroxide solution (7 * 0  ml. of 2 . 5 8  N , 0 .0 2 J mole) 
and benzyl chloride ( 2 . 7  ml., 0 , 0 2 5  mole) were added
It.ib
dro;ov/ise. After lie a. ting gently under reflux for J hr., 
va ter va s a. d 8 eel to the mix tur e followed hy extraction 
with ether. The ethereal solution was washed with dilute 
sodium hydroxide solution to remove unreacted phenolic 
material, and on distillation of the ether, m ethyl 
5 - h en z yl oxy th iona.ph th en - 2 -. carboxyls, t e wa s isolated as an 
oil .
hyd rolys is of tVie ester with 2N-sodium hydroxide 
solution ( 1 0 0  ml.) in ethanol ( 1 0 0  ml.) by heating on 
t'-’e steam bath for 45 min. gave, on ac id if ica, tion of 
th ^  basic so lilt ion with dilute hyd.rochloric acid, 
5-benzyloxyth ionamohth en-2 -ca rboxyl ic acid. Prisms (J.IO g . , 
5 2/ ) from methanol had m . n . 220-221° (Found; C, 6 7 .6 ; 
h , 4.J. requires- C, 6 7 .6 ; H, 4 . ) .
(b) To 5 -hydroxythionaphthen-2-carboxylic acid 
(2.50 g . , 0.01 J uiol e) dissolved in sodium hydroxide 
solution ( 2 7 * 0  ml. of N, 0 . 0 2 7  mole) and ethanol (2 5 ml.), 
benzyl chloride ( J .2 ml,, 0 .0 2 7  mole) was added dropwise 
and. the so lu th on heated under reflux for J hr. On 
cool in r , b an z yl. 5-b enzyloxy th iona oh th en - 2 - carboxyl a t e 
s epa na. t ed. , a d wa .? f i_ 1 1 er ed and washed th oroughl.y wi th 
wa ter to r em o v e so d i urn c hio ri d e an d un r e a c t e d sod ium s alt. 
Fine needles with m .u , 112-119° were obtained from
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m etha no1 (Found; C, 7j'5î h , 4.8. requires
G , 7 J . S ; H , 4. 87' ) .
Hydrolv^sis of the benzyl ester was accomplished, 
by hea.ting for 1 hr, with 2N - sod ium hydroxide solution 
in ethanol ( 1 :l) . 5“^^ ^^ -3'’^ h3xythionaphthen-2-carboxylic 
acid (2.0 g., 5 Ja ) separated on acid if ica. tion with 
dilute hydrochloric acid, e.nd formed cubic crystals 
with m.p. 220° from methanol, ho depression was observed, 
in a nixed m.p. with sample prepared by method (a).
5-BenzyloxV-2-(norpho1inocarbonyl)-th ionaph th en 
(CYIIl) 5 - Tipn zyloxy th ionaph then - 2- carboxyl ic acid
(1.0 g ., J .5 mmole) wa s dissolved in thionyl chloride 
(10 rnl.), and heated gently under reflux for 2 hr.
Til e crystalline acid chloride obtained on distillation 
of the excess thionyl chloride _in vacuo was dissolved, 
in a mi n in urn amount of ice-cold pyridine (5 ril . ) .
Morpholine (0.6l ml., 7*^ mmole) was added dropwise,
and the solution aliowed to stand at room temperature
for JO min. 5-B enzyloxy-2 - ( mornholinocarbonyl)-th ionanh then
separated, on the addition of water ( 200 ml.) , and
f o rm e d vh i t e plates ( 0 . 70 g . , 5 7a ) v.d. th m.p. 120° f ron
m ethanol ( Found : C, 68.5; II, 5*5* ^^ oy.iires
1.08
o o . 0 ; R , 5 . 45 ) .
J-Bcn. 2"( m o r u h o 1 i n o m e t h y 1. ) - th ion aph then
( C rx) .- 5- Pen zyloxy-2-(mornholino carbonyl)-th ionanhthen 
(0.50 g.) and lithium aluminium hyd ride (l.O g.) in 
dry ether (I50 ml.) were heated gently under reflux 
for 4 hr. X-ater was added dropwise to decompose the 
e x c e s s  of lithium aluminium hydride, and. the mixture 
shaken vRth sodium hydroxide solution. The ether 
layer was sena ranted, and on distillation of the ether 
, - benzyl oxy-2-( moroholinometh.yl) - th ionanh then wa s obtained. 
The crystalline amine hydrochloride (0.J2 g ., 6Op) 
hrd m.p. 2 2 5-224° (from ethanol).
Other related benzyloxy-amides and benzyloxy- 
anines were prepared and are listed in ta ble 7 *
Table 7
B en zy 1 oxy-am in e m .n .(amid e )
5 -benzyloxy- 2 -( d. im ethyl aminom ethyl ) - thionaph then 118
o
5-benzyloxy- 2 -(p y rro 1 id inomethyl)-thionaph th en^ IJ 2 - 1 5  4
o
5-benzyloxy- 2 -(piper id inom ethyl)-th ionaphthen 145
o
_L vy
An lyse s
m . n * ( a.m in e) H eauir ed
8 b- 8 7 .8 ° G, 72. 1 ; ’E, 6.9 0 , J2 .6 ; 11, 6 .4 /
78-79° C, 7 1 .8 ; n, 9.6 0, 71.2; II, 9 . 7 /
108° C, 7 4 .7 ; II, 6 . 9  0 , 7 9 .I; H, 6.9/
analysed, as the benzq/^loxy-aTnide.
b--H3^droxy-2 -( mo m h o  1 inom eth 2^1 ) - th ionanh then .( CX ) . - 
J-henzylox^'"- 2 - ( mornh ol in om ethyl ) - thionaph then hydrochlorid e 
(0.25 g.) was warmed on the steam bath with concentrated 
'i 2V ’ro chlor ic acid (10 ml.) for 1 hr. The solution was 
riS.d e basic with sodium hydroxide solution, filtered., 
and the filtrate saturated, c/ith carbon dioxide ( pIT 3. J ) .
5 -Jiydroxy- 2 -( mornhol inomethyl) - th ionanh th en wa s o b ta.in ed 
on ether extraction and formed white prisms (0.09 2 p.,
55/ ) with m.p. 1 7 3 ° from eth^vl acetate (Found; C, 6 2 .7 ?
R, 5 .7 . 5 --^2 =^ requires C, 62.6; IT, 6.15).
Other h^/droxy-amin es prepared, b^  ^ the same 
procedure wer e 2 - ( d irn e th y 1 amino m e th^ ; 1 ) -b-h^^d roxy- 
th i.on a nh th en m . p . 153° ( F o T.in d : C, 6 J . 6 ; li, 5*3.
C.^^H^^1T03 requires G, 6 5 ,7 ; R , 6 . jf ) , and. 5-hydroxy- 
2 - ( uyr ro 1 i d inom eth ]/1 ) - 1 11 iona nh th. en m . p . 1 2 5 ° ( Found :
, 66.9; h , 5.9. 0^ -R., requires G , 66.9; H, 6 .55 ) .
-LJAi
e th i o c i d e s . - The following m eth iodides wer e 
also prepared from the corr espond ing aunines and io do - 
methane in ethanol, and cri^ sta.lli s ed f ron ethanol 
7,_ ( d in eth ]Alarn inon ethyl )-th iona.ph th en rn ethiod.id e m.p. IJ 2- 
19 5°, J-(nyrrolidinomethyl)-thionaphthen n eth io d id e m.p.
15 5°, J-(piperid inomethyl)-thionaphthen methiod id e m.p.
195-196°, and J-( mo rob o 1 in om e th ]''l ) -1 li i o nanh t h en 
VI eth iodide m.. n . 207-209 ° .
9-13 enzyl oxy- hromo th ion a.nh th en ( GXVÎI ) . - 
Bromo-5-h]^ d ro yyth iona.ph th en (7*26 g., 0.0 J2 mole)
wa. q dissolved in li- so d ium hydroxide solution ( 51 . 6 ml.,
0 .0 J2 mol.e), benzyl chloride added ( J . 6 4 ml., 0 .CJ2 mol e) , 
and the mixture heated under reflux for 4 hr. On cooling, 
t)ie reaction mixture vn.s made basic by the addition of 
further sodium h2u1roxide solution, and extracted with 
e th er . J - .Benzyl ox]'- 5-bromo thionauh then wa. s obtained a. s 
an oil on remova.l of the ether b]r distillation, but 
crysta.llised as white needles (4,84 g.) with m.p. 74-75 
from dieth]^! ether or acetic acid (Found; G, 5^*7î 
n, 5 *7 * ^15"] requires G , 5^*4; fl, J .57-) •
J-Bromo-5-hydroxythionaphthen (1.4 g .) wi th 
m.p. 1 j6° was recovered by acidifica.tion of the basic
o
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solution with dilute Tnydro chloric acid, and. crystallisation 
from light petroleum (h.p. 60-80°),
5 - h eu 7.yl oXyth iona vh th en - 5- ca rho xyi j ç e.c id ( CJ.YITT) 
Glean dr 2^ m agues ium turnings (5.0 g * ) were suspended 
in a solution of J - h en z\^loxy- J-bromo th iona ph th en (5.20 g., 
0.01b rnole) and methyl iodide (lO.l ml., 0.l6 mole) in 
dr2'" ether ( 400 ml.), a.nd the resulting mixture warmed 
g'e.ntljV under reflux for 5 • 11 wa s found necessary
to initiate the reaction b]/ scratching the magnesium 
tu-^nings with a glass rod. Small pieces of solid, 
carbon dioxide were added to the cooled reaction 
ixtu.r e for I5 minutes, and the Grig-nard complex 
d ecomno s PC by the addition of d ilut e h 2'd ro chlor ic 
acid. The ethereal 1 a %' e r wa s separated and extracted 
with dilute sodium bm^^droxide solution. 5- Benzyloxy- 
th ionanh th en- 5-ca r box2^11 o acid, wa s obtained on acidifies, tion 
of this basic solution, and formed white prisms 
(2.22 g. , 487) with m.p. 224° from eth 2^1 acetate 
( Found ; C , 67 .2 ; H, 4.6. 0 S requires 0, 67.6;
-L o 12 5
H , 4. 57 ) .
5-?en720..ox2^ -9-bromo thi.onaphthen was recovered 
from the ethereal solution.
Then on 12^ 2 eouivalents of methi^ l iodide were
employed, the yield of acid was 207.
5 - Ben z 2^ 1 ox y- 5 - th i o n. aph th en - a c e t am i d e ( CXIX)
A. solution of 5 -henz2/loxy thionaphth en- J-carboxyl ic acid 
(0.48 g. ) in ’a.nalar’ benzene (20 ml.) and th ion 2^ 1 
chloride (4 ml.) was heated, under reflux for 45 min.
The benzene and excess thionyl chloride were removed 
b.y distilla.tion under reduced pressure, and the acid 
chloride dissolved in ether. Excess of an ethereal 
solution of d iazom etha.n e was added, and the solution 
.^llov^ ed to stand for 24 hr. On removal of the ether 
Ipr distillation at room temperature under reduced 
'oressure, the diazoketone wa s obtained as yellow cubic 
c r y s t a 3. s .
To a solution of the diazoketone in dioxan (6 ml.) 
at 6o \  cone cn tr a t ed ammonium h2“droxide solution (4.5 ml.) 
and 10  ^ silver nitrate solution ( 0 .9 ml.) were added, 
and after heating for 2 hr. under reflux, 5-benzyloxy- 
5 ■-1 h i. o n a T.h 11'^ e n - a cet fi mi.de wa s i sol a. t ed b]^  th e a d d i t ion 
of water. It formed vli i t e pi a. tes (0.20 g., 407 ) with 
m.p. 171° from etli2^ 1 acetate (Found; C, 69.2; R, ^,1.
0 g yE Or, 3 r eq u ires C , 6 8 . 7 ; R , 5 . la ) .
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5- ( 2 '-Am ino e thyl)-5 -b en z y1o xy th ion a uh th en 
Viydro chloride (GXX).- h-Benz^/loxy-J-thionaphthen- 
acetamide (0.12 g . ) was dissolved in dr 2/ ether ( 100 rnl.) 
containing 1 i th inm a.lnminium hydride (l.O g. ) , and 
the solution heated g en tl]/ under reflux for é hr. Rater 
was e.doed gradually to decompose the excess lithium 
aluminium h 2^ dride, the ether solution sha.ken with dilute 
sodium h2Vroxide sol.ution, and the ether la2^ er separated.
e a min e was obtained as an oil (0,10 g.) on distillation 
of the ether.
The a min e h 2’ 5 r o ch 1 o r i d e was prepared, and formed, 
crystals (O.O9O g ., 70/) with m.p. 278-281° from 
ethanol (pound; G, 6 5.9 ; R , 5.5. G^^H^ ^ CIROG requires
G , 65.9; ÎI. 5 . 7/ ) .
5- Pen zyl ox2/- 5 -( 2 ^ - n i trovin2^1 ) - thi on anh th en (CXXTY).
The acid chloride, obtained from 5-bçnz2R.ox2Athionaphthen-
5 - ca rboxyAlic acid (O.JO g.) b2-^ gen tlv^  heating under
reflux for 50 min. in thion2''l chloride (10 ml.), was
dried thoroughli/ under vac urn n and dissolved in ethv'lene
gl2^ col dimethyl ether (2 ml,). To the solution cooled
by a meth2^1ated spirit - solid carbon dioxide mixture,
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lithium tri-t-butox2Vluminoh2Vride ' (0.46 g.) dissolved
in. ethylene g 1 c o 1 d im e thv'l etiier (j ml.) wap added 
slowly. The reaction mixture was allowed to come to 
room temperature over a period of JO min., and poured, 
into we ter.
The oil obtained on ether extraction wap. 
Immediately dissolved in nitronethane (j ml.), and 
heated, gently on the steam hath in the presence of 
anmoninm acetate (0.20 g.) for JO min. The product 
obtained on distillation of the nitromethane a.t reduced, 
pressure '-."a p dissolved, in benzene and chr om a to gr a.ph ed 
on grade J s^lumina. Yellow cipasta 1 s of J - b enzi/loxy- 
5 -( 2 * -n i. t r o V i n 1 ) - th i on a -^-"h th en with m.p, 149 w ere 
obtained, from ethj^l acetate (Found; C, 66.0; li , 4.1.
C, T'O S renuires C, 6 5 .6 ; H, 4.27).
1 f 1. J J
9-R.ydroy.y thiona.-ohthen- 5 -carboxylic a c i d (CXXI).- 
J - Ben z\"lo xy th ion aph th en- J-ca rboxyl i c acid (0.55 g.) 
wr. s dissolved in acetic acid. ( ? 5  ml.) and concentrated.
ro chlor ic acid (25 ml.), and heated on the s t ea^ m 
bath for J hr. The reaction mixture was evaporated to 
dryness under reduced pressure, and the crude solid 
sublimed at 1 8 0 ° / 0 .5 m m . Fine white crystals (0 . J2 g ., 
847) of 5 -hvdroxythionanh th en-5-carboxyli c ac^d were
1±0
obtained , and h s. d m.p. 2 é 0 ( F o un d ; C , 56.4; F , J , J ,
C ^ R/0 3 renuires C , 55*3; R , J . 17 ) .
5 -R y d ro r y -  ^ -hpV -^ o y vn n tb yl th ion auh th en ( C XXII ) . - 
5 -R j''d rox^/thionaph tb en-J-CA rboxp'l io a o i d ( 0.226 g.) 
and lithium aluminium hi^dride (0*5 R • ) wer e dissolved 
in d r y  ether ( 2 5 O ml.) a.nd heated under reflux for 24 hr. 
The excess 1 i th i urn aluminium h]/dr ide was decomposed by 
the careful addition of water, followed b^  ^ the addition 
of dilute hp^dro chlor i c acid. The ether 1 a 2: e r was separated 
r T, d on. A t p t. i 1 1 a t ion o f th e e th er , 5 -h 2"d ro x -h y ro x y -
Vijbh i on r. -oh th en wa. s o b ta in ed . Ill i t e cr ,y s ta. 1 s ( 0 . 1 5  T • » 
7 9 7 ) from e th 1. acetate had m . ;o . 1. / 6 -1 7 8 ( Found ; C, 6 0 .O;
R , 4.0. C^R^OgS requires C, 6 0 .O; R, 4.57),
5 -Jiyd roxy - 2 - hydroxym e thy 1 1 hiona nh then . - A 
solution of rneth^/l 5 - E 2'^ d r o x t h i o n a n h t h e n - 2 - c a r b o x 1 a. t e 
( 2 . 5 5  g • ) A n d. 1 i. th ium a lum i n ium h d  r i d e ( 0  . 5 0  g . ) in 
tetrh^'^drofuraîi (80 ml.) was heated under reflux for 
J hr. The excess 1 i th iuu" a.l urn in ium hydride was decomposed 
h y  the careful addition of water. Dilute sulphuric acid 
war a.dded to dissolve the inorganic material, and the 
t e -h r a.h d r o f 1.1 r a n re o v e d Iq/- distill a. tion. The a.l coho 1
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s isolated 1»}^ ether extraction and formed white plates 
( 1 . 6 0  p., 7J7 ) with m,o, 1 9 frorn eth^^l acetate 
(Found: C, éo.l: H, 4 . J. C^K^O^S requires C, 60.O;
I I ,  4 . 5 7  ) .
J - G 2/an o - 5 - n i t r o th i o n auh t hen . - J-Brono - J -nitro - 
th ion auh th en (5.0 p., O.OI 9 mol e) and cuprous c2v.nide 
(1.7 P*, 0 . 0 1 9  mole) were bested under refl.ux for 4y hr. 
in e ui nol in e (40 m 1 . ) and the hot solution poured into 
0TT_n ro ohl or i c said ( 200 ml,). After f il tr a tion , the 
sol iR' vroduct w":.s extrr'cte" '"'i th hot ethane 1 frorv 
--^ 1 i„ c h 5 - c 2/ a n o - 5 - n i. t r o t h i o n s 'n then c r 2’ s t a. 11 i. s e d as X> s 1 e 
2" ell ow plates (2*7 p . , 6g‘/) wi th m.p. 180° (Found:
G, 5 5 . J; R, 2.2. requires G, 5J.0; R, 2.0/).
1- ( 5 ^ - rl2Ad ro >~2^th ionanh th en - 2 ' - 2/1 -ca r bonyl ) - 2- p- 
to 1 u e n e [;u 1 hon y 1 h 2 d^ra z i n e ( CXXVII ) . - Methyl ^ “Ry^roxy- 
th ionaph th en-2-carbox 2''l a t e (4.0 p.) w-as dissolved in 
methanol (80 ml.), hp-^ d r a, a in e hydrate (10 ml.) added, 
and the solution heated under refl^rx fov 4 hr. The 
acid h jV r a z i. d e cr 2"? ta 11 i s ed out of the hot solution 
and forioed pale 2^ 7^1. oix needles ( J . 6 4 p., GI^-/ / with m.p.
20 2-284° from acetic acid..
u-To 1 u ene su 1 nhon 2  ^1 chloride (2.58 p., 0.014 mole)
in d r 2^ p2"r i c.in e ( JO rnl.) vas added dropvrise to an ic e - cold 
solution of the hp^dr azid e (2,84 g,, 0.014 mole) in d,r2^  
pyridine (90 ml.) over a period of 50 min. The solution 
va,s allowed to stand for a further 50 rain, at room 
temperature, and poured into water (1500 ml.). 1 -( 5 ' -hydr 0 x 2^ • 
t h i o na nh th en - 2 ^ - "/I - ca r hon2^11 - 2 - n- to In en e sul -nh nn 2^1 h 2" d r a z in e 
was obtained b2^  filtration, and formed pale 2dollow prisms 
( 5 . 5 9  g . , 6 9 7.' ) with m.p. 215° from e thj'l acetate (Pound;
C , 5 5.0; n, 4.5. requires C, 55.0; H, 5.97 ) .
5 d r n X 2't h ionawh th en - 2 - a 3 d eh d p ( CXXY III) . -
1- ( 5 ’ -II2" d roxv^'th iona.ph th en - 2 * - 2^ 1- carbon yl ) -2-n- tolu en e- 
su 1 -eh o n 2'’! h y a, r a z in e ( 1. 8 6 g . , 5.15 mmole) in e th .yl en e
ylj^eol (8 ml . ) Tw. s heated wi th an oil bath, and, a.t 1 6  0 ° 
anh 2 Arons sodium carbonate (1.56 g ., 12.8 mmole) added. 
Vigorous effervesence took place, and after 90 sec., 
the r e a 0 1 i o n m i x t u r e wa s poured into wa. ter. The a 1 d eh 2^  d e 
was extracted vitli ether, and formed pale 2" ol. low needles 
( 0 , 4 5  g ., 4 7 7 ) with m.p. 195-196° from ethyl acetate
(pound; G, 6 0 ,7 ? 5.6. C^P/0 S requires C, 6 0 .7 ; E» J • 4f ) .J I.' /.
5 -Mx-V r o X 2"- 2 - ( 2 * -n i t r o v in2  ^1 ) - th i on a nh th en (CXXIX)
To a solution of 5 -h 2'd r o x 2^ t ti i o n a ph t h en - 2 - a 1. d eh 2^ d e (0.79 f*)
in nitromethane ( 6  ml.,), ammonium a.c eta te (0 .2 ^ g.)
s added, and the mixture heated gently/ on the steam 
ha. th for JC min. On cooling, cr^^stals of 5 -t yd r o x /^- 2- 
( 2 ' -n i tro V in.3/1 ) - th i.ona.nh th en separated, and. were filtered 
and wa sh e d with hot water, Bed cubes ( 0 , 6 0  g ., 6 l7 ) from
Athyl acetate had m.p. 2 2 0 " (p o u n d ; C , 54.7; R , J .J .
XO^S renuires C, J 4. 5 : h, 5.27).
5 -F ird r_o X V- 9 - ( 2 ' t^,h 2/1 - 2  * -n i. t r o v i n ]/! ) - th i on a nh th en 
(CXXXI).- To a solution of l-lm/d roxy th ionaphth en - 2- 
a 1 d eh j; d e (1.4 b g.) in nitroethane ( 1 0  ml.), ammonium 
acetate (0.40 g . ) t'a s added, and the mixture heated 
g en 11_ 2  ^ on the steam bath for JO min. On cooling,
5 - h d r o y V- o - ( 2 ’ - e th y l. - 2 ' -n i tro v i n y 1 ) - t Vi i o n anh th en 
r epa r a ted ; 2" e 1 ] o w cubes ( 1 . 2 0  g . , 6 27 ) from eth 2^1 acetate
h p. a m.p. 22J.5-224° (I-'oun-^ : C, / 6 .1 ; H. J.5- 
renuires C, / 6 . 2 ; II, J . 8/) .
2 - ( 2 ’ - 4 m i n o p th yl . ) - 5 -h rox 2^ th ion a.oh th en h 2''d ro ch lor i d e 
(CXXX).- lithium a.l urn in ium h 2nd r i d. e ( 0 s added
to dry t e tr adny d ro f u.ran (150 ml.) in the flask of a Soxhlet 
extractor , and J - h 2'd rox]^- 2 -( 2 • -ni tro vinyl ) - thionaph th en 
(0.2 J g .) extracted from the thimble for J hr. The
r.o lut ion clevelopei p men colouration. After the 
euceso lithiun aliuninium hjoride had heen deconposec^ "by 
the careful ad c) it ion of vater, 2N-sodium hydroxide solution 
(100 Till . ) Ycas added, and the tetrahydrofuran removed by 
d i st illation . The basic solution vas filtered, sa. tura t ed 
'rith carbon dioxide (pH 8 .%), and extracted, continuously 
vith eth er for 2 4 hr. Try hydroyen chloride v'as passed 
into the ether solution, and 2- ( 2 '-a m in o e th y1 )-d-h y d r o xy- 
th i on a nh th en h d r o ch ?. o r i d e vas pre cio it a. ted.. It formed 
i t e elates ( G . 12 d 5 • b 2>. ) vi th m . p . 2° 6  ^ from me th a no 1
( Ho un d : C , 8 2 . c ; H , p.p. q'‘ 2  ^ ^  ^^ pu ir es C , ^2.1;
"7 . .Up).
2-( 2 ’ -Am inoo ro nyl ) - 8 -h yd r oxy th iona.oh th en hy d ro - 
r> h 1 o r i d e (CXXXIl) h-Hydrox3:-2-( 2 ^ -methyl-2-Lni trovinyl ) - 
th iona.nh th en vas reduced vi th lithium aluminium hyd ride 
in t etrah^'d rof u.r an bv the same procedure a s vas employed 
In the case of _^^--hydroxy-2 -( 2 '-nitrovinyl )-thionaph then ,
- /h i t e n e e d 1, e s of 2 - ( 2 ' - am i n omro^^yl ) - 8 -h yd roxy th ion a oh th en
h 2 d no chi or id e v^ere obt % ined from methanol, and had. m , o .
2 7 - 2 70 ^ ( 1 oun d ; C , 5 4,2; H , . R . C ^ i“]4^  I- 03 r ec u i r e s
C , ^4.2: H , d . o'). ) .
1 1. h o y y th "i o in d o x y 1 ; ^-_e thoxy- ^ -oxo-^ , -- d ihydro- 
th iona -nh th en (OXXXJII).- H in e vhite needles of é - ethoxy • 
t.hioindoxyl vi th m.p, 1 2 ^^ (lit.,"' 124-12^^ ) vrere
oota ined by crystallisation (from ethyl acetate) of the 
erude compound supulled by TCI Dyestuffs Division,
o -Z th o X ^ t^h i o n uh th en-^-aceti c a c i d ( GXXXYI ) . -
'^ Ithyl bromac e ta t e ( 5 4 .A 0.20^ mole) and small pieces
of zinc wool ( 1 5 . 7  a,, 0.20é mole) vere added to a solution 
of b- eth oxyth io in d oxyl (20,0 p., O.l.OR mole) in dry 
hpTizene (ICC ml.) a.nd dry toluene (100 ml.) . The m.ixture 
V a ^  h eat ly p gn tl 3  ^ to initiate the reaction, al loved to 
stand for JC m i n . . and then heated under refl.ux for 4 hr.
T's. e reaction mixture va s dilu. ted mi th benzene ( 400 ml.), 
shah en 7si th dilute sulnhuric acid, and the or panic layer 
se%)ara ted and filtered. The dark viscous oil o b ta.ined on 
d i s t il la. t ion of th e benzene asnd toluene yv-s hydrolysed 
by her? tiny Y'ith 2u - sodium h%/droxid e solution ( 200 ml.) 
in ethanol ( 2^0 rnl.) on the steam bath for 2 hr. The 
hot solution mas filtered after treatment vith charcoal. 
Acidification vith dilute hydrochloric acid pave ?_n oily 
ureciuitate mhich T ? s dissolved in ether and extracted
T1 th sodium carbonate solution, é-Z tho xy th iona uh th an-
-I. ±
a. cet i. c a cid vas obtained by a cid if ica tion of the carbonate 
solution, and separated, b^  ^ ether extraction. It formed, 
vh i t e needles (4.8 p., POy ) vi th m . p • lOp^ from benzene 
( ^ 'omnd ; 0, 6 1 . 4 ; hi, ^.2. C M O S  r ecu ires C, ol.O; H, 8 . l7 ) .
J c: 12 y
Th ion a n h then - ^ -a ce tic acid . - Th i o in d o x ^ ^  (8.0 p., 
0.08J mole), onrified by steam d.i s t il la ti o n , vas dissolved 
in dry tolu ene ( 100 ml.), and ethi'’!bromac eta,te (1.57 8 * ’
0 . 0 7 7  mole) and zinc (2.18 p., O.OJJ mole) added. The 
mixture -mas vm rm e d p en tl y to initiate the reaction, 
and then heated under refl’ix for 2 lir. vi th stirring . 
m u on.aphthen-i~a ce tic acid, ■'.'"as ’i s o l a t e d  by the technicu.e 
emolo^^ed fo. the separation of 6- et.h oxyth ionaohthen- 8- 
acptic acid, '".h i t e needles from' benzene had m.p. IDS-1.09 
109°).
6 - Z t h o X y t li i o n a nh t u en - 8 - a c e t a m i d e ( C X a X VII ) . - 
u - Z t h o X y t h i o n a. p h t h c n - 1 - a. c e t i c acid ( 2 . 0  p.) v"a s dissolved, 
in benzene (40 ml.), ox alyl chloride (2.0 ml.) added., 
and the solution heated pent],y under reflux for JO min . 
The acid chloride remained a. a light coloured, oil 
on d istilla tion of the benzene and excess oxalyl chloride 
at reduced pressure. Concentrated ammonia solution vas
s elded, and the a.m i d e s epar a t ed as a vhite solid; plates 
( ]. . 7 ? 8 • 5  7 e ) from, methanol had m.p. 1^ 7" (round;
C, él.d; H, 5 .4 . requires G, él.J; H, 5 . ) .
7 - ( 2 ’ - An in o e th - et ho y y th i o n avh th en (CXXXYIIl) .
7 - h th o X y th i o n a nh th en - J - a c e ta ni i de ( 1 . 0 0  g . ) va s add ed .to 
a sol u t i on of lit h 1 1 ni a. 1 ur'. i n i u m h y d r i d. e ( J . 0  g . ) in dry 
et!), er (80 ml.), and the solution heated gently under 
reflux for 4 hi . The exoess of lithium aluminium hydride 
va s decomposed by the careful addition, of va ter. Dilute 
sodium hydroxide solution vas -’dded, and the ether 1.  ^y e r 
epa T’ a t e d . e a m i e  ( 0  . 7 8 g «  ^ 8 J/ ■ ) va. s obtained a. s a. n
oil on d i s t ill a t ion of the ether, and formed a solid.
-•a t er- soluble hyd robromid 0 .
''./ith bensovl chloride in pyridine at 8 ^ (80 min.) ,
dietby/I ether had m.p. 1 0 0  .8 - 1 0 1 . 1  ^  (pound; C, 1 0 * ? . ;
II, 4.1, C n _i'0_ S requires C, 1 0 * 1 ;  H, 5 «97 ) •
^-( 2 * -Amino ethyl ) - 4-hg'd roxy thionaoh th en hydro chlori d e 
(GXXXIX).- J-(2'-Amino ethyl)-b-ethoxythionaphthen ( 0 .5 0  g .) 
va, s h e a. t e d un d e r r ef 1 u x v i th h y drobr omic a. c i d (10 ml.) 
in acetic acid (10 ml.) for l4 hr. The solution vv,.s
vu? n e basic v-'i t h dilute sod ii.in hydroxide solution, filtered, 
and the filtrate saturated vi th carbon dioxide (pH S.j). 
Continuous extraction of this solution vi th ether for 4 
h r‘ . gave 8 - ( P * - a n i n o e t h j  1 ) - 4 - yd r o x y th i o n a ~nh t l i en (0.24 g . , 
44/ ) as a. glass. The a mine h yd ro ch 1 or i d e vas prepared, 
and forned prisms vi th m.p. 205 ^  froT? ethanol (Hound:
1, 82.c; H, 5.1. G ^CIFOT requires C, 5 2 . J; n, 5 .8/■ ) •
h-acetyl- 8-(2'-amino ethy11- 4 - e th o x y th i on aoh the n .- 
8-( 2 ^ -Amino ethyl)-4— ethoxy tV\i on a ph then (0.17 g . , J.J mmole) 
r s d i s s 0 i. v e d in d r y pyr id in c ( 8 m 1. ) , a c e t y 1 chlori d e 
(0.28 ml . , 8 . 8 ^^nioiç) a 88 ed d roy'7'n. s e , and the reaction
ml ]-1ur e a 11 oy:ed to stan d for 10 min. On add i t ion. of va ter, 
the a a» e tyl 8 mr 1 v a. tiv e cry s tall i s ed . It formed fine 
'H"i i t e pi a tl et s (0.75 T * , G 2 7 ) ’>’"1 th m.p. 123-129^ from 
1, cnzene (Hound: C, 4 8.3; lî , 4.8. requires
C, 4 7.3; H, 4 .57') .
7 -H thoXy-1 -m e thyl- 8 , 4- d ihi^dro th iona oh theno( 2 , 8-C ) - 
u yr id ± n e d ro chi or i. de ( CXIr) , - H-Ac etyl- J-( 2 ’ - amino ethyl) - 
4 - ethoxythion avhthen (O. 5 O g.), phosphorus pentoxide 
( 1 . 0  g .), and phosphorus oxychloride (l.O g .) ver e heated 
under reflux for 4 hr. in dry toluene (40 rnl.); water
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TBS added dropwise, and the aqueous layer separated., 
made basic vi.th sodium hydroxide solution, and. extracted 
( 8 t ini es) with benzene. Chr oma. togr auhy on grade 8 
a lu. in in a in benzene gave the tricyclic u ro duct as a 
crystalline solid (0.28 g . , JOg ) rn. th m.p. 47-4 9°. The 
h yd r o ch 1 o r i. d e s prepared and formed colourless plates 
"'ith m.p. 212-210*^ from ethanol. (Hound: C, 4o. 2 ; H, 5*5*
1 4"l4GIh'0.1 r equir e s G , 5 9 • 7 î H , 5 . 77 )
7.-P t])ox.y-~i -m p th ,y 1 th ion a.nh t h en o ( 2 , 8 -G ) uyr i. dine 
( GXLI ) . - 7 -nthoxy-1 -m ethyl t.hionach th en o ( 2 , 8 - G )  pyridine 
va p, lar epar ed from the corn esuond.ing 8 , 4- d ihydro compound 
uy d ehyd ro g en a. t ion . I h  e, diliydro compound (0.40 g . ) 
and A d a m ’s catalyst ( 0.40 g . ) vrer e heated together for 
-C 'Tt.in . at 1 9 0-200^. The residue was extracted, •''rith 
Vn n t m eth^ no 1 , tr ea ted x" I th act i.7 a ted ch a rco a. 1 , and 
f i 1 1 er e d . Vh i t e ne ed 1 e s (0.1 7 5  2 • > 4 8/ ) of 7 - e th o x y - 1- 
m e t tgy 1_ th i o n a vh. th eno ( 2 , 8 -0 ) uy r i dine v  ere f o rm ed f r o m  
m e t h a n o l .  Gn standi.ng in c o n t a c t  -eith m e t h a n o l  a.t roo m  
t e m p e r a t u r e  for 1 hr., t h e s e  n e e d l e s  w e r e  converted, into 
or i sm s vi th m . [). 1 J ].  ^ ( lo un d : 0 , 4 J . 8 ; H  , 5 • • G ^   ^ G T
G , 49.1: o, 5.47).
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Appnndi': ^
A 1 i o f  thionaphthcn derivatives, prepared 
for ‘biolopicn.l teetinr, is provided;
5 ~ ( .irn iron e th^ ri ) - th ion ,aph th on ( 0  )
)-( D in o til yl an in on e th y 1 ) -thionaphthen ( Cl )
5 - ( 7?yr r o 1 i ê inon e th 3/I ) - 1hion a ph th en
J - ( A i peri cl in on o th yl ) - th ion a,ph then
J-( ? * -'iethvlplper idinorriethyl ) -thionaphth on
p-( j ' orpho 1.inorn ethyl) - t h i o n a p h t h en ( CXi)
i - ( Cycle h e % y 1 a. n 1 n o n ethyl ) - th ionaphth en
J-( rDinethyla.minomethyl) - thionaphthen methiodide
/-( pyrro 1 i(1 inomethy 1  ) - th iona.ph th en lo ethiodi d.e
5 -( Piperidinornethyl ) -thionaphthen riethiodide
1 - ( T ' o r ph o 1 in o m e tIi 37I ) - 1h i o n a,ph th en ni e t h i o d i d e
d -Ben a y ]. o x 3/- 2 - ( d i ni e th y 1 am i n o n eth^ /l ) - th ionaphth en 
d - B en z 3’lo xy- 2- ( pyrr o 1 i dinon e th jri ) - th ion aph th en 
5 - Ben zyloX3'“- 2-( piper i dinom e th3"1 ) - thlonaph th en 
d-Benzylox3r-2-( norpholinoraethyl ) - thionaphthen ( CX)
2 - ( Din ethp'^laminorri e tli3^ l) -p -h]/d r o xy th ion aph th en 
5 - It y d r o ::y - 2 - ( p 3^ r r o 1 i d in o m e t h 3/" 1 ) - t h i o n a ph th en
5 -iljrdrox]/- 2 -( nor phol inorn e tiiT^ 'l ) - th ion aph then ( CZ ) 
p - .Ajn i n o - 2 - ( di n e t h, 3" 1 a n i n o rn e th }l) - thio n a ph th on 
d - Anino- 2-{ p 3/rrol idinou e  th 3^1 ) - thionaph th en 
^ -Anino-2-( piper id inon e thd^l ) - thiona ph th en
I R  )
J) - An in o - 2- ( no r pho 1 inon. e th2/l ) -.th ion aph th cn ( CX lY )
J - ( 2 * - .,%.n i n o e th ]. ) - 5 - h e n z yl. o x  y  t h i o n a p h  t h en ( C X X  )
2-( 2 ’ - Anino oth]/! ) -^-hp^droxy thionanhthen ( CXXX)
2-( 2 * -Aninopropj^l ) -h-hynrox^/thionaph then ( 0.XX7CIT) 
é-Xthox3"thionaphthen-;)-acetic acid ( OX.XX Y I )
J-( 2 * - An ino eth]?"!) -(j- ethoxy thionaphthen ( OXXXYIII)
J) - ( 2h - An i n o e t h 30„ ) - b - h. 3/ d roxy thiona p h th en ( C X X XI }C ) 
y - X th o X 3"-1 -n e t h 3^ 1 - a , 4-dihydro thionaphth eno( 2, A-O ) p3/T idin e ( CX 
7 -Xthoxy-3.-rieth3^ 1 th ionaphth eno( 2, a-G ) p 3^ r.idin o ( 0X1,1)
